INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50315,14795,'6fadde9e-dab3-4d01-b3fb-795eef7eff2f',500.0,NULL,24,7,'Standard Dose: 500.0mg. DOSAGE AND ADMINISTRATION (See INDICATIONS AND USAGE and CLINICAL PHARMACOLOGY.) Adults: Infection* Recommended Dose/Duration of Therapy Community-acquired pneumonia (mild severity) Pharyngitis/tonsillitis (second line therapy) Skin/skin structure (uncomplicated) 500 mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 through 5. Acute bacterial exacerbations of chronic obstructive pulmonary disease (mild to moderate) 500 mg QD x 3 days OR 500 mg as a single dose on Day 1, follo...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50316,24925,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50317,21963,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50318,30120,'N/A',0.0,NULL,24,7,'يعزز وظائف المخ ويحسن الوظائف الإدراكية ، ويستخدم للقلق والاكتئاب ونقص الانتباه و اضطراب النوم والاكتئاب السريري.','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50319,8157,'2b29422e-54d5-4a49-8522-e9cf752368c3',5.0,NULL,NULL,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION Administer NAYZILAM by the nasal route only. (2.2) Initial Dose: Administer one spray (5 mg dose) into one nostril. (2.2) Second Dose: One additional spray (5 mg dose) into the opposite nostril may be administered after 10 minutes if the patient has not responded to the initial dose. (2.2) Maximum Dosage and Treatment Frequency: Do not use more than 2 doses of NAYZILAM to treat a seizure cluster. It is recommended that NAYZILAM be used to treat no more than one episod...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50320,7570,'N/A',7.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 7 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50321,21089,'5d140f06-e46b-4cdd-97e4-37b6cf4ade13',200.0,NULL,NULL,7,'Standard Dose: 200.0mg. DOSAGE AND ADMINISTRATION Strongyloidiasis The recommended dosage of STROMECTOL for the treatment of strongyloidiasis is a single oral dose designed to provide approximately 200 mcg of ivermectin per kg of body weight. See Table 1 for dosage guidelines. Patients should take tablets on an empty stomach with water. (See CLINICAL PHARMACOLOGY, Pharmacokinetics.) In general, additional doses are not necessary. However, follow-up stool examinations should be performed to verify eradication of infecti...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50322,2432,'ADB54FE50FCC4A01AFC64AA3D3DB45BB',40.0,NULL,24,7,'Standard Dose: 40.0mg. DOSAGE AND ADMINISTRATION Instructions for Use/Handling FLUXID™ Tablets Just prior to administration, remove the tablet from the bottle with dry hands. Immediately place the FLUXID™ Tablet on top of the tongue, wait until it dissolves, then swallow with saliva. The tablet typically disintegrates in less than 2 minutes. Administration with liquid is not necessary. Duodenal Ulcer Acute Therapy The recommended adult oral dosage for active duodenal ulcer is 40 mg once a day at bedtime. Most patients...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50323,17962,'ba296354-b01c-4b3f-a980-b8a0ac370932',30.0,NULL,24,7,'Standard Dose: 30.0mg. DOSAGE AND ADMINISTRATION The usual dose is 1 to 2 tablespoonfuls (15 to 30 mL, containing 10 g to 20 g of lactulose) daily. The dose may be increased to 60 mL daily if necessary. Twenty-four to 48 hours may be required to produce a normal bowel movement. Note: Some patients have found that lactulose solution may be more acceptable when mixed with fruit juice, water or milk....','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50324,5458,'dbd309c5-7205-41e3-b8c4-cb06df375528',1500.0,NULL,NULL,7,'Standard Dose: 1500.0mg. DOSAGE AND ADMINISTRATION The usual dietary intake of potassium by the average adult is 50 to 100 mEq per day. Potassium depletion sufficient to cause hypokalemia usually requires the loss of 200 or more mEq of potassium from the total body store. Dosage must be adjusted to the individual needs of each patient. The dose for the prevention of hypokalemia is typically in the range of 20 mEq per day. Doses of 40-100 mEq per day or more are used for the treatment of potassium depletion. Dosage shoul...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50325,10076,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50326,24726,'N/A',4.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 4 g (عن طريق الحقن). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50327,18835,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50328,3809,'a697e731-8d19-4845-8f31-16c4b19bb338',50.0,NULL,NULL,7,'Standard Dose: 50.0mg. DOSAGE AND ADMINISTRATION Carefully consider the potential benefits and risks of diclofenac potassium immediate-release tablets and other treatment options before deciding to use diclofenac potassium immediate-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). After observing the response to initial therapy with diclofenac potassium immediate-release tablets, the dose and frequency should be adjusted to suit...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50329,19729,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50330,27595,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50331,20321,'N/A',0.0,NULL,24,7,'علاج البواسير -- تقليل الالتهابات الشرجية -- تقليل الحكة والاحمرار -- تقليل الالام الشرجية','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50332,28428,'189ac32d-28b4-47c5-9de6-318e502eff3b',10.0,NULL,12,7,'Standard Dose: 10.0mg. DOSAGE AND ADMINISTRATION Selegiline Hydrochloride Tablets, USP are intended for administration to Parkinsonian patients receiving levodopa/carbidopa therapy who demonstrate a deteriorating response to this treatment. The recommended regimen for the administration of Selegiline Hydrochloride Tablets, USP is 10 mg per day administered as divided doses of 5 mg each taken at breakfast and lunch. There is no evidence that additional benefit will be obtained from the administration of higher doses. M...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50333,7774,'N/A',0.0,NULL,24,7,'1- يوفر حماية للبشرة الحساسة.','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50334,2343,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50335,27113,'8fb45a78-b2d8-45dd-b844-0de21d1fdde9',600.0,NULL,NULL,7,'Standard Dose: 600.0mg. 2 DOSAGE AND ADMINISTRATION LYRICA is given orally with or without food. When discontinuing LYRICA, taper gradually over a minimum of 1 week. DPN Pain (2.1): Administer in 3 divided doses per day Begin dosing at 150 mg/day May be increased to a maximum of 300 mg/day within 1 week. PHN (2.2): Administer in 2 or 3 divided doses per day Begin dosing at 150 mg/day May be increased to 300 mg/day within 1 week Maximum dose of 600 mg/day. Adjunctive Therapy for Adult Patients with Partial Onset Seizure...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50336,29585,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50337,24171,'7d74dfa6-0468-43ad-ad7f-dd90d9ae7706',400.0,NULL,24,7,'Standard Dose: 400.0mg. DOSAGE AND ADMINISTRATION The dose of AVELOX is 400 mg (orally or as an intravenous infusion) once every 24 hours. The duration of therapy depends on the type of infection as described below. For Complicated Intra-Abdominal Infections, therapy should usually be initiated with the intravenous formulation. When switching from intravenous to oral dosage administration, no dosage adjustment is necessary. Patients whose therapy is started with AVELOX I.V. may be switched to AVELOX Tablets when clinic...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50338,20632,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50339,4895,'056485b6-8bba-4a21-ae00-cdb4e7ae4bfa',0.0,NULL,NULL,7,'2 DOSAGE AND ADMINISTRATION Bacterial Vaginosis (female patients 12 years of age and older): Administer a single 2-gram packet of granules once orally, without regard to the timing of meals. (2.1) Trichomoniasis (patients 12 years of age and older): Administer a single 2-gram packet of granules once orally, without regard to the timing of meals. Treat sexual partners with the same dose and at the same time. (2.2) Sprinkle entire contents of packet onto applesauce, yogurt or pudding and consume a','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50340,18541,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50341,30094,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50342,32851,'N/A',0.4,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.4 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50343,30227,'b7b0b1a0-2ab3-4697-bee4-0cd7fd5088b9',5.0,NULL,24,7,'Standard Dose: 5.0mg. DOSAGE AND ADMINISTRATION Adults and children 12 years of age and over The recommended dose of CLARINEX Tablets or CLARINEX RediTabs Tablets is one 5 mg tablet once daily or the recommended dose of CLARINEX Syrup is 2 teaspoonfuls (5 mg in 10 mL) once daily. Children 6 to 11 years of age The recommended dose of CLARINEX Syrup is 1 teaspoonful (2.5 mg in 5 mL) once daily or the recommended dose of CLARINEX RediTabs Tablets is one 2.5 mg tablet once daily. Children 12 months to 5 years of age The ...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50344,33261,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50345,30366,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50346,1802,'N/A',0.0,NULL,24,7,'شامبو للشعر','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50347,13844,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50348,9618,'N/A',3.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50349,15405,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50350,33015,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50351,16650,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50352,10932,'abd1f64e-4283-4370-aae8-3666316aa36e',1.0,NULL,24,7,'Standard Dose: 1.0mg. DOSAGE AND ADMINISTRATION Intramuscular Route Only Adults: The preferred site is the upper outer quadrant of the buttock (i.e., gluteus maximus) or the mid-lateral thigh. Children: It is recommended that intramuscular injections be given preferably in the mid-lateral muscles of the thigh. In infants and small children the periphery of the upper outer quadrant of the gluteal region should be used only when necessary, such as in burn patients, in order to minimize the possibility of damage to the ...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50353,26976,'96425d91-cfe1-477d-a130-b58c330ca8a3',8.0,NULL,24,7,'Standard Dose: 8.0mg. 2 DOSAGE AND ADMINISTRATION 8 mg capsules taken orally once daily with a meal. (2.1) 4 mg capsules taken orally once daily with a meal for those with moderate renal impairment [Creatinine Clearance (CCr) 30-50 mL/min]. (2.2) 2.1 Dosing Information The recommended dose is 8 mg orally once daily with a meal. 2.2 Dosage Adjustment in Special Populations Renal impairment: RAPAFLO is contraindicated in patients with severe renal impairment (CCr < 30 mL/min). In patients with moderate renal impairment...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50354,29764,'6fadde9e-dab3-4d01-b3fb-795eef7eff2f',500.0,NULL,24,7,'Standard Dose: 500.0mg. DOSAGE AND ADMINISTRATION (See INDICATIONS AND USAGE and CLINICAL PHARMACOLOGY.) Adults: Infection* Recommended Dose/Duration of Therapy Community-acquired pneumonia (mild severity) Pharyngitis/tonsillitis (second line therapy) Skin/skin structure (uncomplicated) 500 mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 through 5. Acute bacterial exacerbations of chronic obstructive pulmonary disease (mild to moderate) 500 mg QD x 3 days OR 500 mg as a single dose on Day 1, follo...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50355,23927,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50356,4968,'de8990a6-f3b6-478f-acbe-eda961b6da4b',500.0,NULL,24,7,'Standard Dose: 500.0mg. DOSAGE AND ADMINISTRATION Amoxicillin capsules may be given without regard to meals. However, food effect studies have not been performed with the 500 mg formulation. Neonates and infants aged ≤ 12 weeks (≤ 3 months): Due to incompletely developed renal function affecting elimination of amoxicillin in this age group, the recommended upper dose of amoxicillin is 30 mg/kg/day divided q12h.Adults and pediatric patients >3 months: * Dosing for infections caused by less susceptible organisms should f...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50357,17232,'61bf535a-3ed5-4c50-b285-6dcee0624c2d',360.0,NULL,24,7,'Standard Dose: 360.0mg. DOSAGE AND ADMINISTRATION Patients controlled on diltiazem alone or in combination with other medications may be switched to diltiazem hydrochloride extended-release capsules at the nearest equivalent total daily dose. Higher doses of diltiazem hydrochloride extended-release capsules may be needed in some patients. Patients should be closely monitored. Subsequent titration to higher or lower doses may be necessary and should be initiated as clinically warranted. There is limited general clinical...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50358,22138,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50359,27451,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50360,23754,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50361,28907,'26fcf4be-4785-4922-a37b-4546570a132c',300.0,NULL,6,7,'Standard Dose: 300.0mg. DOSAGE AND ADMINISTRATIONIf significant diarrhea occurs during therapy, this antibiotic should be discontinued (see WARNING box). Adults: Serious infections—150 to 300 mg every 6 hours. More severe infections—300 to 450 mg every 6 hours. Pediatric Patients: Serious infections—8 to 16 mg/kg/day (4 to 8 mg/lb/day) divided into three or four equal doses. More severe infections—16 to 20 mg/kg/day (8 to 10 mg/lb/day) divided into three or four equal doses. To avoid the possibility of esophageal irrit...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50362,20734,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50363,24530,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50364,30105,'N/A',7.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 7 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50365,25700,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50366,2104,'7e41818c-60e9-4bcf-9586-7bb8d33d5e89',500.0,2000.0,24,7,'Standard Dose: 500.0mg. 2 DOSAGE AND ADMINISTRATION •Swallow metformin hydrochloride extended-release tablets whole and never crush, cut or chew (2.1) •Starting dose: 500 mg orally once daily with the evening meal (2.1) •Increase the dose in increments of 500 mg weekly, up to a maximum of 2000 mg once daily with the evening meal (2.1) •Patients receiving metformin hydrochloride (HCl) tablets may be switched to metformin hydrochloride extended-release tablets once daily at the same total daily dose, up to 2000 mg once d...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50367,29372,'N/A',15.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 15 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50368,32650,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50369,4569,'f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8',15.0,NULL,24,7,'Standard Dose: 15.0mg. DOSAGE AND ADMINISTRATION The recommended initial dose is 15 mg daily (7.5 mg b.i.d.). To achieve an optimal therapeutic response, at intervals of 2 to 3 days the dosage may be increased 5 mg per day, as needed. The maximum daily dosage should not exceed 60 mg per day. In clinical trials allowing dose titration, divided doses of 20 to 30 mg per day were commonly employed. The bioavailability of buspirone is increased when given with food as compared to the fasted state (see CLINICAL PHARMACOLOGY...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50370,5907,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50371,24583,'N/A',10.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 10 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50372,10782,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50373,21718,'d0a7247c-5d83-4bc1-840f-c58314d14195',20.0,NULL,24,7,'Standard Dose: 20.0mg. 2 DOSAGE AND ADMINISTRATION •Dose range: 20 mg to 80 mg/day (2.1) •Fluvastatin capsules can be taken with or without food •Do not open fluvastatin capsules prior to administration (2.1) •Adults: the recommended starting dose is 40 mg to 80 mg (administered as one fluvastatin 40 mg capsule twice daily) (2.2) •Do not take two fluvastatin 40 mg capsules at one time •Children with heterozygous familial hypercholesterolemia (ages 10 to 16, inclusive): the recommended starting dose is fluvastatin caps...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50374,983,'A4FD2D68-019F-4C89-8923-4E61262F6EEE',25.0,NULL,NULL,7,'Standard Dose: 25.0mg. DOSAGE AND ADMINISTRATION Diclofenac sodium may be administered as 25 mg, 50 mg, or 75 mg delayed-release tablets. Regardless of the indication, the dosage of diclofenac should be individualized to the lowest effective dose to minimize adverse effects (see CLINICAL PHARMACOLOGY: Individualization of Dosage) Osteoarthritis: The recommended dosage is 100 to 150 mg/day in divided doses, 50 mg b.i.d. or t.i.d. or 75 mg b.i.d. Dosages above 150 mg/day have not been studied in patients with osteoarthr...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50375,26434,'2724a67d-0fc6-402c-8aef-d2d76db74f8e',0.0,NULL,24,7,'See package insert','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50376,12952,'N/A',0.0,NULL,24,7,'انزيمات هاضمة -- لعلاج عسر الهضم واضطرابات الجهاز الهضمي','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50377,5774,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50378,20466,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50379,21010,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50380,25265,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50381,11576,'C33601EC-EF89-4BD4-8485-F81871AFAD94',50.0,NULL,24,7,'Standard Dose: 50.0mg. DOSAGE & ADMINISTRATION Adults (17 years of age and over)For patients with moderate to moderately severe chronic pain not requiring rapid onset of analgesic effect, the tolerability of tramadol hydrochloride can be improved by initiating therapy with a titration regimen: The total daily dose may be increased by 50 mg as tolerated every 3 days to reach 200 mg/day (50 mg q.i.d.). After titration, tramadol hydrochloride 50 mg to 100 mg can be administered as needed for pain relief every four to six...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50382,15978,'N/A',2.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 2 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50383,2289,'1781fc07-5a2a-4b31-aad9-d0457eb704f4',250.0,NULL,24,7,'Standard Dose: 250.0mg. DOSAGE AND ADMINISTRATION Ceftriaxone for injection may be administered intravenously or intramuscularly. Do not use diluents containing calcium, such as Ringer''s solution or Hartmann''s solution, to reconstitute ceftriaxone for injection vials or to further dilute a reconstituted vial for IV administration because a precipitate can form. Precipitation of ceftriaxone-calcium can also occur when ceftriaxone for injection is mixed with calcium-containing solutions in the same IV administration line...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50384,5541,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50385,30958,'7d74dfa6-0468-43ad-ad7f-dd90d9ae7706',400.0,NULL,24,7,'Standard Dose: 400.0mg. DOSAGE AND ADMINISTRATION The dose of AVELOX is 400 mg (orally or as an intravenous infusion) once every 24 hours. The duration of therapy depends on the type of infection as described below. For Complicated Intra-Abdominal Infections, therapy should usually be initiated with the intravenous formulation. When switching from intravenous to oral dosage administration, no dosage adjustment is necessary. Patients whose therapy is started with AVELOX I.V. may be switched to AVELOX Tablets when clinic...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50386,14695,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50387,26578,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50388,13413,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50389,22538,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50390,28038,'N/A',25.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 25 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50391,12231,'fa778759-2b9a-4446-ba06-d3c486019e79',0.0,NULL,NULL,7,'DOSAGE AND ADMINISTRATION The same dosage schedule applies to children and adults. The tablet may be chewed, swallowed, or crushed and mixed with food. Pinworm (enterobiasis) Whipworm (trichuriasis) Common Roundworm (ascariasis) Hookworm Dose 1 tablet, once 1 tablet morning and evening for 3 consecutive days 1 tablet morning and evening for 3 consecutive days 1 tablet morning and evening for 3 consecutive days If the patient is not cured three weeks after treatment, a second course of treatment ','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50392,31211,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50393,26219,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50394,18943,'N/A',4.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 4 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50395,13937,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50396,12559,'A4FD2D68-019F-4C89-8923-4E61262F6EEE',25.0,NULL,NULL,7,'Standard Dose: 25.0mg. DOSAGE AND ADMINISTRATION Diclofenac sodium may be administered as 25 mg, 50 mg, or 75 mg delayed-release tablets. Regardless of the indication, the dosage of diclofenac should be individualized to the lowest effective dose to minimize adverse effects (see CLINICAL PHARMACOLOGY: Individualization of Dosage) Osteoarthritis: The recommended dosage is 100 to 150 mg/day in divided doses, 50 mg b.i.d. or t.i.d. or 75 mg b.i.d. Dosages above 150 mg/day have not been studied in patients with osteoarthr...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50397,16123,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50398,31579,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50399,29638,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50400,23967,'N/A',2.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50401,14637,'de8990a6-f3b6-478f-acbe-eda961b6da4b',500.0,NULL,24,7,'Standard Dose: 500.0mg. DOSAGE AND ADMINISTRATION Amoxicillin capsules may be given without regard to meals. However, food effect studies have not been performed with the 500 mg formulation. Neonates and infants aged ≤ 12 weeks (≤ 3 months): Due to incompletely developed renal function affecting elimination of amoxicillin in this age group, the recommended upper dose of amoxicillin is 30 mg/kg/day divided q12h.Adults and pediatric patients >3 months: * Dosing for infections caused by less susceptible organisms should f...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50402,31907,'ebddb745-81f9-4b25-8739-b2886032ed26',5.0,NULL,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION CIALIS for use as needed: Starting dose: 10 mg up to once daily. Increase to 20 mg or decrease to 5 mg based upon efficacy/tolerability. Improves erectile function compared to placebo up to 36 hours post dose (2.1). CIALIS for once daily use: 2.5 mg taken once daily, without regard to timing of sexual activity. May increase to 5 mg based upon efficacy and tolerability (2.1). CIALIS may be taken without regard to food (2.2). 2.1 Erectile Dysfunction CIALIS for Use as N...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50403,27052,'56a07381-7c51-4607-8131-f925a20d9074',10.0,40.0,24,7,'Standard Dose: 10.0mg. DOSAGE AND ADMINISTRATION Hypertension Initial Therapy: In patients with uncomplicated essential hypertension not on diuretic therapy, the recommended initial dose is 10 mg once a day. Dosage should be adjusted according to blood pressure response. The usual dosage range is 20 to 40 mg per day administered in a single daily dose. The antihypertensive effect may diminish toward the end of the dosing interval regardless of the administered dose, but most commonly with a dose of 10 mg daily. This c...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50404,21916,'f60a672d-8d6d-4d67-9a47-5547357e7b5b',20.0,NULL,24,7,'Standard Dose: 20.0mg. 2 DOSAGE AND ADMINISTRATION Dose range: 10 to 80 mg once daily (2.1). Recommended start dose: 10 or 20 mg once daily (2.1). Patients requiring large LDL-C reduction (>45%) may start at 40 mg once daily (2.1). Pediatric starting dose: 10 mg once daily; maximum recommended dose: 20 mg once daily (2.2). 2.1 Hyperlipidemia (Heterozygous Familial and Nonfamilial) and Mixed Dyslipidemia (Fredrickson Types IIa and IIb) The recommended starting dose of LIPITOR is 10 or 20 mg once daily. Patients who req...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50405,29102,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50406,14819,'6fadde9e-dab3-4d01-b3fb-795eef7eff2f',500.0,NULL,24,7,'Standard Dose: 500.0mg. DOSAGE AND ADMINISTRATION (See INDICATIONS AND USAGE and CLINICAL PHARMACOLOGY.) Adults: Infection* Recommended Dose/Duration of Therapy Community-acquired pneumonia (mild severity) Pharyngitis/tonsillitis (second line therapy) Skin/skin structure (uncomplicated) 500 mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 through 5. Acute bacterial exacerbations of chronic obstructive pulmonary disease (mild to moderate) 500 mg QD x 3 days OR 500 mg as a single dose on Day 1, follo...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50407,939,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50408,15879,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50409,29096,'4902b757-1387-4dc4-a685-ad5af29fe8c2',75.0,375.0,24,7,'Standard Dose: 75.0mg. DOSAGE AND ADMINISTRATION Initial Treatment The recommended starting dose for venlafaxine tablets, USP is 75 mg/day, administered in two or three divided doses, taken with food. Depending on tolerability and the need for further clinical effect, the dose may be increased to 150 mg/day. If needed, the dose should be further increased up to 225 mg/day. When increasing the dose, increments of up to 75 mg/day should be made at intervals of no less than 4 days. In outpatient settings there was no evi...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50410,2099,'c7bc9486-8e61-4ba1-827f-2cd8c304b454',25.0,50.0,24,7,'Standard Dose: 25.0mg. 2 DOSAGE AND ADMINISTRATION CHF Post-MI : Initiate treatment with 25 mg once daily. Titrate to maximum of 50 mg once daily within 4 weeks, as tolerated. Dose adjustments may be required based on potassium levels. (2.1) Hypertension : 50 mg once daily, alone or combined with other antihypertensive agents. For inadequate response, increase to 50 mg twice daily. Higher dosages are not recommended. (2.2) For all patients: Measure serum potassium before starting INSPRA and periodically thereafter. (2...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50411,24654,'2673e4a2-42d3-4100-a651-7c2bbde94e52',0.0,NULL,NULL,7,'DOSAGE AND ADMINISTRATION Denavir should be applied every 2 hours during waking hours for a period of 4 days. Treatment should be started as early as possible (i.e., during the prodrome or when lesions appear).','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50412,9541,'N/A',3.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3.6 mg (عن طريق الحقن). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50413,33531,'N/A',0.0,NULL,24,7,'مكمل غذائى لعلاج حالات فقر الدم ودعم الجهاز العصبي','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50414,33912,'2bd238d4-4657-4341-9c28-1b468b8f3bf8',20.0,NULL,24,7,'Standard Dose: 20.0mg. DOSAGE AND ADMINISTRATION Prior to initiation of caffeine citrate, baseline serum levels of caffeine should be measured in infants previously treated with theophylline, since preterm infants metabolize theophylline to caffeine. Likewise, baseline serum levels of caffeine should be measured in infants born to mothers who consumed caffeine prior to delivery, since caffeine readily crosses the placenta. The recommended loading dose and maintenance doses of caffeine citrate follow. Dose of caffeine ...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50415,9418,'N/A',1.5,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 1.5 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50416,6748,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50417,32961,'N/A',3.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3.6 mg (عن طريق الحقن). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50418,9074,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50419,21251,'0277db2d-7c81-4cd0-ac19-fa12b5721428',1.0,NULL,24,7,'Standard Dose: 1.0mg. 2 DOSAGE AND ADMINISTRATION Before Extraction: Administer 10 mg/kg actual body weight of tranexamic acid injection intravenously with replacement therapy. (2.1) After Extraction: Administer 10 mg/kg actual body weight 3 to 4 times daily for 2 to 8 days. Infuse no more than 1 mL/minute to avoid hypotension. (2.1) Reduce the dosage for patients with renal impairment. (2.2, 8.6) 2.1 Recommended Dosage The recommended dose of tranexamic acid injection is 10 mg/kg actual body weight intravenously adm...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50420,4999,'db08d5f3-6713-4372-a66c-fad3018ef5c6',0.0,NULL,24,7,'2 DOSAGE AND ADMINISTRATION The recommended dosage is one drop in the affected eye(s) once daily in the evening. TRAVATAN Z ® (travoprost ophthalmic solution) should not be administered more than once daily since it has been shown that more frequent administration of prostaglandin analogs may decrease the intraocular pressure lowering effect. Reduction of the intraocular pressure starts approximately 2 hours after the first administration with maximum effect reached after 12 hours. TRAVATAN Z® m','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50421,16307,'698AAA0A-9FD3-40C2-EC93-0DC2170A75BA',0.0,NULL,NULL,7,'Dosage and Administration A small amount of ointment placed in the lower conjunctival sac every three hours, or more frequently if deemed advisable by the prescribing physician. Administration should be continued day and night the first 48 hours, after which the interval between applications may be increased. Treatment should be continued for at least 48 hours after the eye appears normal.','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50422,29415,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50423,12613,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50424,28477,'c1730a51-4383-4c61-a9a1-7e1326bd0abe',5.0,10.0,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION Adult recommended starting dose: 5 mg orally once daily with a maximum of 10 mg orally once daily. (2.1) Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg orally once daily. (2.1) Pediatric starting dose: 2.5 mg to 5 mg orally once daily. (2.2) 2.1 Adults The usual initial antihypertensive oral dose of NORLIQVA is 5 mg orally once daily, and the maximum dose is 10 mg orally once daily. Small, fragile, or elderly patie...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50425,14584,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50426,28447,'0277db2d-7c81-4cd0-ac19-fa12b5721428',1.0,NULL,24,7,'Standard Dose: 1.0mg. 2 DOSAGE AND ADMINISTRATION Before Extraction: Administer 10 mg/kg actual body weight of tranexamic acid injection intravenously with replacement therapy. (2.1) After Extraction: Administer 10 mg/kg actual body weight 3 to 4 times daily for 2 to 8 days. Infuse no more than 1 mL/minute to avoid hypotension. (2.1) Reduce the dosage for patients with renal impairment. (2.2, 8.6) 2.1 Recommended Dosage The recommended dose of tranexamic acid injection is 10 mg/kg actual body weight intravenously adm...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50427,27289,'73b5e1f4-40a6-4009-9b2c-6401c7538586',120.0,NULL,24,7,'Standard Dose: 120.0mg. DOSAGE AND ADMINISTRATION The dose of phenobarbital must be individualized with full knowledge of it particular characteristics. Factors of consideration are the patients age, weight, and condition. Sedation For sedation, the drug may be administered in single doses of 30 to 120 mg repeated at intervals; frequency will be determined by the patient''s response. It is generally considered that no more than 400 mg of phenobarbital should be administered during a 24-hour period. Adults: Daytime Sedat...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50428,19963,'N/A',2.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50429,17262,'6541ab19-3cfc-4786-9cfe-0455f428edb5',60.0,NULL,24,7,'Standard Dose: 60.0mg. DOSAGE AND ADMINISTRATION THE CAPSULES SHOULD BE SWALLOWED WITHOUT CHEWING TO AVOID LOCAL IRRITATION OF THE MOUTH AND THROAT. Valproic Acid is administered orally. Valproic Acid is indicated as monotherapy and adjunctive therapy in complex partial seizures in adults and pediatric patients down to the age of 10 years, and in simple and complex absence seizures. As the Valproic Acid dosage is titrated upward, concentrations of phenobarbital, carbamazepine, and/or phenytoin may be affected (see PRE...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50430,17243,'6906b0b4-1944-40f0-844a-e0db72ba4675',5.0,NULL,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION The recommended starting dose of memantine hydrochloride tablets is 5 mg once daily. The dose should be increased in 5 mg increments to 10 mg/day (5 mg twice daily), 15 mg/day (5 mg and 10 mg as separate doses), and 20 mg/day (10 mg twice daily). The minimum recommended interval between dose increases is one week. The dosage shown to be effective in controlled clinical trials is 20 mg/day. Memantine hydrochloride can be taken with or without food. If a patient misses ...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50431,16518,'26fcf4be-4785-4922-a37b-4546570a132c',300.0,NULL,6,7,'Standard Dose: 300.0mg. DOSAGE AND ADMINISTRATIONIf significant diarrhea occurs during therapy, this antibiotic should be discontinued (see WARNING box). Adults: Serious infections—150 to 300 mg every 6 hours. More severe infections—300 to 450 mg every 6 hours. Pediatric Patients: Serious infections—8 to 16 mg/kg/day (4 to 8 mg/lb/day) divided into three or four equal doses. More severe infections—16 to 20 mg/kg/day (8 to 10 mg/lb/day) divided into three or four equal doses. To avoid the possibility of esophageal irrit...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50432,19175,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50433,25513,'ed826777-b8c4-4d35-aa64-a4c28452baa8',10.0,NULL,24,7,'Standard Dose: 10.0mg. 2 DOSAGE AND ADMINISTRATION The maximum recommended dosage is 10 mg twice daily (approximately 12 hours apart). There is no evidence of additional benefit with doses greater than 10 mg twice daily. Adverse reactions, including seizures, were more frequent at higher doses. (2.1) Take with or without food. Administer tablets whole; do not divide, crush, chew, or dissolve (2.2) Patients should not take double or extra doses if they miss a dose. (2.2) Estimated creatinine clearance (CrCl) should be ...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50434,22512,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50435,16404,'f9e1a84b-d19e-46c5-b40f-944ac1543dac',1.0,NULL,NULL,7,'Standard Dose: 1.0mg. 2 DOSAGE AND ADMINISTRATION Store cisatracurium besylate injection that minimizes the possibility of selecting the wrong product (2.1) Administer intravenously only by or under the supervision of experienced clinicians familiar with drug''s actions and possible complications (2.1) Use only if personnel and facilities for resuscitation and life support, and a cisatracurium besylate antagonist are immediately available (2.1) Use a peripheral nerve stimulator to determine adequacy of blockade (e.g.,...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50436,16358,'2a33f95e-4245-4437-86a9-fcfc87e26edb',10.0,NULL,24,7,'Standard Dose: 10.0mg. 2 DOSAGE AND ADMINISTRATION Escitalopram tablets USP should be administered once daily, in the morning or evening, with or without food. Escitalopram tablets USP should generally be administered once daily, morning or evening with or without food (2.1, 2.2). Indication Recommended Dose MDD (2.1) Adults (2.1) Initial: 10 mg once daily Recommended: 10 mg once dailyMaximum: 20 mg once daily GAD (2.2) Adults (2.2) Initial: 10 mg once dailyRecommended: 10 mg once daily No additional benefits seen at ...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50437,8266,'5777b8a8-ada6-4950-8548-43a1de11f075',10.0,NULL,24,7,'Standard Dose: 10.0mg. 2 DOSAGE AND ADMINISTRATION •Assess renal function before initiating and as clinically indicated. Assess volume status and correct volume depletion before initiating. (2.1) •Recommended dosage is 10 mg orally once daily in the morning, taken with or without food. (2.2) •For additional glycemic control, dosage may be increased to 25 mg orally once daily in patients tolerating JARDIANCE. (2.2) •Withhold JARDIANCE for at least 3 days, if possible, prior to major surgery or procedures associated wit...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50438,22489,'N/A',10.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 10 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50439,4691,'5e2dbda9-aceb-4bfb-9c3f-e7b6118f580c',16.0,NULL,24,7,'Standard Dose: 16.0mg. DOSAGE AND ADMINISTRATION Instructions for Use/Handling ondansetron orally disintegrating tablets:Do not attempt to push ondansetron orally disintegrating tablets through the foil backing. With dry hands, PEEL BACK the foil backing of 1 blister and GENTLY remove the tablet. IMMEDIATELY place the ondansetron orally disintegrating tablet on top of the tongue where it will dissolve in seconds, then swallow with saliva. Administration with liquid is not necessary. Prevention of Nausea and Vomiting A...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50440,18605,'43fdfd16-c723-452a-9c1d-accf6f7c622e',250.0,NULL,24,7,'Standard Dose: 250.0mg. DOSAGE AND ADMINISTRATION Ethosuximide capsules are administered by the oral route. The initial dose for patients 3 to 6 years of age is one capsule (250 mg) per day; for patients 6 years of age and older, 2 capsules (500 mg) per day. The dose thereafter must be individualized according to the patient''s response. Dosage should be increased by small increments. One useful method is to increase the daily dose by 250 mg every four to seven days until control is achieved with minimal side effects. D...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50441,29352,'ba296354-b01c-4b3f-a980-b8a0ac370932',30.0,NULL,24,7,'Standard Dose: 30.0mg. DOSAGE AND ADMINISTRATION The usual dose is 1 to 2 tablespoonfuls (15 to 30 mL, containing 10 g to 20 g of lactulose) daily. The dose may be increased to 60 mL daily if necessary. Twenty-four to 48 hours may be required to produce a normal bowel movement. Note: Some patients have found that lactulose solution may be more acceptable when mixed with fruit juice, water or milk....','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50442,33495,'N/A',0.4,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.4 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50443,23666,'29ccf947-91c1-405a-aba6-5889e3c75d70',2.0,NULL,24,7,'Standard Dose: 2.0mg. DOSAGE AND ADMINISTRATION INFANTS: 2 mL (200,000 units) four times daily (in infants and young children, use dropper to place one-half of dose in each side of mouth and avoid feeding for 5 to 10 minutes). NOTE: Limited clinical studies in premature and low birth weight infants indicate that 1 mL four times daily is effective. CHILDREN AND ADULTS: 4–6 mL (400,000 to 600,000 units) four times daily (one-half of dose in each side of mouth). The preparation should be retained in the mouth as long as...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50444,1461,'00a642fd-fbbc-41d8-ac62-83444f0b8284',0.0,NULL,NULL,7,'DIRECTIONS: USE AS DIRECTED. STOP USE IF REDNESS, IRRITATION, ITCHING AND/OR DARKENING OCCURS.','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50445,25463,'00a642fd-fbbc-41d8-ac62-83444f0b8284',0.0,NULL,NULL,7,'DIRECTIONS: USE AS DIRECTED. STOP USE IF REDNESS, IRRITATION, ITCHING AND/OR DARKENING OCCURS.','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50446,22396,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50447,6535,'N/A',0.0,NULL,24,7,'حقن تحت الجلد لجعل الشفاه اكبر -- لخفض الخطوط والتجاعيد من الوجه والرقبة','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50448,24936,'N/A',7.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 7 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50449,26718,'N/A',2.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50450,5136,'0cc52ac5-77ec-4d66-a770-762a1a960914',20.0,NULL,24,7,'Standard Dose: 20.0mg. 2 DOSAGE AND ADMINISTRATION Recommended Dosage: Healing of Erosive Esophagitis: 20 mg once daily for 8 weeks. (2.1) Maintenance of Healed Erosive Esophagitis: 10 mg once daily for up to 6 months. (2.1) Relief of Heartburn Associated with Non-Erosive Gastroesophageal Reflux Disease: 10 mg once daily for 4 weeks. (2.1) Treatment of H. pylori Infection: see full prescribing information. (2.1) See also full prescribing information for the recommended dosage by indication for patients with renal or h...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50451,2107,'d64a0f0e-1fa4-47cb-a59e-d294e001ba53',100.0,NULL,8,7,'Standard Dose: 100.0mg. DOSAGE AND ADMINISTRATION 100 mg Tablets: Average adult dosage is two tablets 3 times a day after meals. 200 mg Tablets: Average adult dosage is one tablet 3 times a day after meals. When used concomitantly with an antibacterial agent for the treatment of a urinary tract infection, the administration of Phenazopyridine HCl should not exceed 2 days....','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50452,18454,'AACEE94D-15AF-4CCC-9CC9-6CD52905EC4E',120.0,NULL,NULL,7,'Standard Dose: 120.0mg. DOSAGE AND ADMINISTRATION Epirubicin Hydrochloride Injection is administered to patients by intravenous infusion. Epirubicin Hydrochloride Injection is given in repeated 3- to 4-week cycles. The total dose of Epirubicin Hydrochloride Injection may be given on Day 1 of each cycle or divided equally and given on Days 1 and 8 of each cycle. The recommended dosages of Epirubicin Hydrochloride Injection are as follows: Starting Doses The recommended starting dose of Epirubicin Hydrochloride Injection...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50453,27171,'fb77dffc-b38d-461c-8926-bc57bef1f321',3.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50454,24250,'N/A',0.0,NULL,24,7,'مضاد للروماتيزم -- التهاب المفاصل -- لبناء تآكل المفاصل والغضاريف لحالات الخشونة','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50455,24547,'14d74b63-34ca-4897-bfdd-3e3952ab6088',800.0,NULL,24,7,'Standard Dose: 800.0mg. DOSAGE AND ADMINISTRATION CHC Monoinfection The recommended dose of ribavirin tablet is provided in Table 5. The recommended duration of treatment for patients previously untreated with ribavirin and interferon is 24 to 48 weeks. The daily dose of ribavirin tablet is 800 mg to 1200 mg administered orally in two divided doses. The dose should be individualized to the patient depending on baseline disease characteristics (e.g., genotype), response to therapy, and tolerability of the regimen (see T...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50456,32862,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50457,8371,'7d74dfa6-0468-43ad-ad7f-dd90d9ae7706',400.0,NULL,24,7,'Standard Dose: 400.0mg. DOSAGE AND ADMINISTRATION The dose of AVELOX is 400 mg (orally or as an intravenous infusion) once every 24 hours. The duration of therapy depends on the type of infection as described below. For Complicated Intra-Abdominal Infections, therapy should usually be initiated with the intravenous formulation. When switching from intravenous to oral dosage administration, no dosage adjustment is necessary. Patients whose therapy is started with AVELOX I.V. may be switched to AVELOX Tablets when clinic...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50458,8379,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50459,11525,'N/A',7.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 7 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50460,2210,'d9243be5-bd27-4f37-ba8b-9f6f55f8b3e4',600.0,600.0,24,7,'Standard Dose: 600.0mg. DOSAGE AND ADMINISTRATION (see INDICATIONS AND USAGE for Indicated Pathogens) The recommended dosage and duration of treatment for infections in pediatric patients are described in the following chart; the total daily dose for all infections is 14 mg/kg, up to a maximum dose of 600 mg per day. Once-daily dosing for 10 days is as effective as BID dosing. Once-daily dosing has not been studied in skin infections; therefore, cefdinir for oral suspension should be administered twice daily in this in...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50461,20480,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50462,2478,'N/A',0.4,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.4 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50463,31628,'N/A',0.0,NULL,24,7,'كريم مساج لتخفيف الألم.تنشيط الدورة الدموية.إزالة التوتر.يمنح الجسم الاسترخاء.يحد من توتر العضلات.','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50464,2606,'N/A',0.2,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50465,1923,'N/A',1.5,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 1.5 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50466,3931,'N/A',3.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3.6 mg (عن طريق الحقن). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50467,25241,'N/A',0.2,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50468,16195,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50469,1784,'N/A',0.11,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.11 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50470,22959,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50471,22127,'ca79dddc-3911-472b-bda7-a23351be09af',24.0,NULL,24,7,'Standard Dose: 24.0mg. 2 DOSAGE AND ADMINISTRATION Amitiza should be taken twice daily orally with food and water. Physicians and patients should periodically assess the need for continued therapy. Chronic idiopathic constipation 24 mcg taken twice daily orally with food and water (2.1) Irritable bowel syndrome with constipation 8 mcg taken twice daily orally with food and water (2.2) 2.1 Chronic Idiopathic Constipation 24 mcg twice daily orally with food and water. 2.2 Irritable Bowel Syndrome with Constipation 8 mcg...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50472,25020,'N/A',0.4,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.4 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50473,8352,'N/A',0.2,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50474,8451,'ae3defca-06d5-49ac-8a27-be5c4e9304d1',0.0,NULL,24,7,'DOSAGE AND ADMINISTRATION A small amount of Centany (mupirocin ointment),2% should be applied to the affected area three times daily. The area treated may be covered with a gauze dressing if desired. Patients not showing a clinical response within 3 to 5 days should be re-evaluated.','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50475,25983,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50476,26878,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50477,16775,'A36432F9-BDDD-4B22-BE6D-ED6AC2B3846A',600.0,NULL,24,7,'Standard Dose: 600.0mg. DOSAGE AND ADMINISTRATION Gabapentin capsules is given orally with or without food.If gabapentin dose is reduced, discontinued or substituted with an alternative medication, this should be done gradually over a minimum of 1 week (a longer period may be needed at the discretion of the prescriber). Postherpetic Neuralgia In adults with postherpetic neuralgia, gabapentin therapy may be initiated as a single 300-mg dose on Day 1, 600 mg/day on Day 2 (divided BID), and 900 mg/day on Day 3 (divided TI...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50478,25116,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50479,21575,'N/A',3.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50480,14204,'N/A',0.11,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.11 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50481,6353,'24d10449-2936-4cd3-b7db-a7683db721e4',260.0,NULL,NULL,7,'Standard Dose: 260.0mg. 2 DOSAGE AND ADMINISTRATION • Do not substitute ABRAXANE for other paclitaxel products. (2.1) • Extravasation: Closely monitor the infusion site for extravasation and infiltration. (2.1) • Metastatic Breast Cancer (MBC): Recommended dosage of ABRAXANE is 260 mg/m2 intravenously over 30 minutes every 3 weeks. (2. 2) • Non-Small Cell Lung Cancer (NSCLC): Recommended dosage of ABRAXANE is 100 mg/m2 intravenously over 30 minutes on Days 1, 8, and 15 of each 21-day cycle; administer carboplatin on Da...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50482,19292,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50483,6041,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50484,16819,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50485,17723,'A0EEEC15-C76D-41DF-80F3-5572C9857DA6',5.0,NULL,24,7,'Standard Dose: 5.0mg. DOSAGE AND ADMINISTRATION The initial dosage of prednisolone tablets may vary from 5 mg to 60 mg per day depending on the specific disease entity being treated. In situations of less severity, lower doses will generally suffice, while in selected patients higher initial doses may be required. The initial dosage should be maintained or adjusted until a satisfactory response is noted. If after a reasonable period of time there is a lack of satisfactory clinical response, prednisolone should be dis...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50486,13285,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50487,21437,'9bc31f67-cfce-4ad6-9c07-3845ead3542c',300.0,NULL,24,7,'Standard Dose: 300.0mg. DOSAGE AND ADMINISTRATION Carefully consider the potential benefits and risks of a ketoprofen immediate-release capsules and ketoprofen extended-release capsules and other treatment options before deciding to use ketoprofen immediate-release capsules and ketoprofen extended-release capsules. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). After observing the response to initial therapy with ketoprofen immediate-release ca...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50488,29156,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50489,16135,'N/A',0.4,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.4 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50490,1012,'614e6649-a0e1-4428-855b-363abdb126d8',50.0,NULL,24,7,'Standard Dose: 50.0mg. 2 DOSAGE AND ADMINISTRATION Should be administered by trained healthcare providers (2.1) Ephedrine sulfate injection, 50 mg per mL, must be diluted before administration as an intravenous bolus dose. (2.1) Bolus intravenous injection: 5 to 10 mg as needed, not to exceed 50 mg. (2.1) 2.1 General Dosage and Administration Instructions Ephedrine sulfate injection, 50 mg per mL must be diluted before administration as an intravenous bolus to achieve the desired concentration. Dilute with normal sali...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50491,22488,'N/A',7.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 7 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50492,7554,'7b38ac8a-4540-4eb2-aedd-9aa966d22190',100.0,NULL,24,7,'Standard Dose: 100.0mg. DOSAGE AND ADMINISTRATION Therapy should be individualized according to patient response. Use the smallest dosage necessary to achieve the required response. Adults For EdemaThe usual adult dosage is 25 to 100 mg daily as a single or divided dose. Many patients with edema respond to intermittent therapy, i.e., administration on alternate days or on three to five days each week. With an intermittent schedule, excessive response and the resulting undesirable electrolyte imbalance are less likely t...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50493,13002,'N/A',1.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 1 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50494,21177,'N/A',0.0,NULL,24,7,'علاج حالات التهاب المفاصل والغضاريف -- بناء انسجة المفاصل والغضاريف -- مضاد لالتهاب المفاصل والعظام -- مضاد للروماتيزم -- تقليل الام المفاصل والركبة -- زيادة لزوجة السائل الغضروفي -- تقليل التورم الناتج من الالتهاب.','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50495,29947,'51fffac8-fb6e-4f7f-b2de-440252781a42',6.0,NULL,12,7,'Standard Dose: 6.0mg. DOSAGE AND ADMINISTRATION Gentamicin injection may be given IM or IV. The patient’s pretreatment body weight should be obtained for calculation of correct dosage. The dosage of aminoglycosides in obese patients should be based on an estimate of the lean body mass. It is desirable to limit the duration of treatment with aminoglycosides to short term. Patients with Normal Renal Function Adults The recommended dosage of gentamicin injection for patients with serious infections and normal renal func...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50496,1038,'N/A',0.2,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50497,7889,'N/A',0.0,NULL,24,7,'مكمل غذائى غنى بالزنك لدعم صحة الجسم مثل الشعر والبشرة والجهاز المناعى','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50498,14108,'1448e72e-dc7f-4618-9b37-a82c59823839',1.0,NULL,24,7,'Standard Dose: 1.0mg. 2 DOSAGE AND ADMINISTRATION Enter section text here One 1 mg tablet taken once daily ( 2.1) 2.1. Recommended Dose The dose of anastrozole tablets are one 1 mg tablet taken once a day. For patients with advanced breast cancer, anastrozole tablets should be continued until tumor progression. Anastrozole tablets can be taken with or without food. For adjuvant treatment of early breast cancer in postmenopausal women, the optimal duration of therapy is unknown. In the ATAC trial anastrozole tablets w...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50499,32449,'N/A',10.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 10 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50500,28989,'b3bbc16e-8305-469a-9dc3-8e698339a98b',10.0,NULL,24,7,'Standard Dose: 10.0mg. DOSAGE AND ADMINISTRATION For most patients, the recommended starting dose of LEVITRA is 10 mg, taken orally approximately 60 minutes before sexual activity. The dose may be increased to a maximum recommended dose of 20 mg or decreased to 5 mg based on efficacy and side effects. The maximum recommended dosing frequency is once per day. LEVITRA can be taken with or without food. Sexual stimulation is required for a response to treatment. Geriatrics: A starting dose of 5 mg LEVITRA should be consi...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50501,8462,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50502,15766,'7464e883-6286-4f04-ae38-b7ddc3fec754',0.0,NULL,24,7,'DOSAGE AND ADMINISTRATION Mycelex® Troches are administered only as a lozenge that must be slowly dissolved in the mouth. The recommended dose is one troche five times a day for fourteen consecutive days. Only limited data are available on the safety and effectiveness of the clotrimazole troche after prolonged administration; therefore, therapy should be limited to short term use, if possible.For prophylaxis to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by co','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50503,2249,'N/A',4.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 4 g (عن طريق الحقن). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50504,24214,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50505,13403,'d5a26c5e-9c3e-4781-8c08-62b91d21a68d',0.0,NULL,24,7,'DOSAGE AND ADMINISTRATION Sotret should be administered with a meal (see PRECAUTIONS: Information for Patients).The recommended dosage range for Sotret is 0.5 to 1.0 mg/kg/day given in two divided doses with food for 15 to 20 weeks. In studies comparing 0.1, 0.5, and 1 mg/kg/day,8 it was found that all dosages provided initial clearing of disease, but there was a greater need for retreatment with the lower dosages. During treatment, the dose may be adjusted according to response of the disease a','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50506,1149,'14d06124-1eef-4f97-b1f3-18620819ae1a',100.0,NULL,24,7,'Standard Dose: 100.0mg. DOSAGE AND ADMINISTRATION Loading Dose Due to the long half-life in patients with RA and recommended dosing interval (24 hours), a loading dose is needed to provide steady-state concentrations more rapidly. It is recommended that leflunomide therapy be initiated with a loading dose of one 100 mg tablet per day for 3 days. Elimination of the loading dose regimen may decrease the risk of adverse events. This could be especially important for patients at increased risk of hematologic or hepatic tox...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50507,20015,'N/A',2.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50508,20584,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50509,6997,'N/A',7.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 7 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50510,22783,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50511,13105,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50512,18252,'2bd238d4-4657-4341-9c28-1b468b8f3bf8',20.0,NULL,24,7,'Standard Dose: 20.0mg. DOSAGE AND ADMINISTRATION Prior to initiation of caffeine citrate, baseline serum levels of caffeine should be measured in infants previously treated with theophylline, since preterm infants metabolize theophylline to caffeine. Likewise, baseline serum levels of caffeine should be measured in infants born to mothers who consumed caffeine prior to delivery, since caffeine readily crosses the placenta. The recommended loading dose and maintenance doses of caffeine citrate follow. Dose of caffeine ...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50513,3489,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50514,23599,'N/A',60.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 60 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50515,23605,'a323ebd8-ef1b-439b-93d1-ba73a5b0127d',30.0,NULL,NULL,7,'Standard Dose: 30.0mg. DOSAGE AND ADMINISTRATION DO NOT ADMINISTER NIMODIPINE CAPSULES INTRAVENOUSLY OR BY OTHER PARENTERAL ROUTES (see WARNINGS ). If nimodipine is inadvertently administered intravenously, clinically significant hypotension may require cardiovascular support with pressor agents. Specific treatments for calcium channel blocker overdose should also be given promptly. Nimodipine is given orally in the form of soft gelatin 30 mg capsules for subarachnoid hemorrhage. The recommended oral dose is 60 mg (tw...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50516,3662,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50517,29474,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50518,8254,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50519,17538,'c68bb847-5d17-4d63-99d4-e72f92a31392',8.0,NULL,24,7,'Standard Dose: 8.0mg. DOSAGE AND ADMINISTRATION There is no fixed dosage regimen for the management of diabetes mellitus with glimepiride or any other hypoglycemic agent. The patient’s fasting blood glucose and HbA1c must be measured periodically to determine the minimum effective dose for the patient; to detect primary failure, i.e., inadequate lowering of blood glucose at the maximum recommended dose of medication; and to detect secondary failure, i.e., loss of adequate blood glucose lowering response after an init...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50520,11354,'fc61fd7e-63ca-4714-851f-31b2a045903d',300.0,300.0,24,7,'Standard Dose: 300.0mg. DOSAGE AND ADMINISTRATION Theophylline (Anhydrous) Extended-Release Tablets 200 or 300 mg Tablets can be taken once a day in the morning or evening. It is recommended that Theophylline (Anhydrous) Extended-Release Tablets be taken with meals. Patients should be advised that if they choose to take Theophylline (Anhydrous) Extended-Release Tablets with food it should be taken consistently with food and if they take it in a fasted condition it should routinely be taken fasted. It is important that ...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50521,1101,'ab23bc6e-b6a8-165f-e053-2a95a90ab144',5.0,NULL,NULL,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION The recommended dosage of BARHEMSYS: Prevention of PONV, either alone or in combination with another antiemetic: 5 mg as a single intravenous dose infused over 1 to 2 minutes at the time of induction of anesthesia. (2.1) Treatment of PONV: 10 mg as a single intravenous dose infused over 1 to 2 minutes in the event of nausea and/or vomiting after a surgical procedure. (2.1) See full prescribing information for preparation and administration instructions. (2.2) 2.1 Reco...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50522,27121,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50523,7418,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50524,27699,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50525,13716,'26fcf4be-4785-4922-a37b-4546570a132c',300.0,NULL,6,7,'Standard Dose: 300.0mg. DOSAGE AND ADMINISTRATIONIf significant diarrhea occurs during therapy, this antibiotic should be discontinued (see WARNING box). Adults: Serious infections—150 to 300 mg every 6 hours. More severe infections—300 to 450 mg every 6 hours. Pediatric Patients: Serious infections—8 to 16 mg/kg/day (4 to 8 mg/lb/day) divided into three or four equal doses. More severe infections—16 to 20 mg/kg/day (8 to 10 mg/lb/day) divided into three or four equal doses. To avoid the possibility of esophageal irrit...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50526,8507,'c1730a51-4383-4c61-a9a1-7e1326bd0abe',5.0,10.0,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION Adult recommended starting dose: 5 mg orally once daily with a maximum of 10 mg orally once daily. (2.1) Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg orally once daily. (2.1) Pediatric starting dose: 2.5 mg to 5 mg orally once daily. (2.2) 2.1 Adults The usual initial antihypertensive oral dose of NORLIQVA is 5 mg orally once daily, and the maximum dose is 10 mg orally once daily. Small, fragile, or elderly patie...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50527,1545,'7e41818c-60e9-4bcf-9586-7bb8d33d5e89',500.0,2000.0,24,7,'Standard Dose: 500.0mg. 2 DOSAGE AND ADMINISTRATION •Swallow metformin hydrochloride extended-release tablets whole and never crush, cut or chew (2.1) •Starting dose: 500 mg orally once daily with the evening meal (2.1) •Increase the dose in increments of 500 mg weekly, up to a maximum of 2000 mg once daily with the evening meal (2.1) •Patients receiving metformin hydrochloride (HCl) tablets may be switched to metformin hydrochloride extended-release tablets once daily at the same total daily dose, up to 2000 mg once d...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50528,13043,'8609ed02-0b30-4c82-bab1-4d51d92ec224',20.0,NULL,NULL,7,'Standard Dose: 20.0mg. 2 DOSAGE AND ADMINISTRATION Indication Adult Pediatric MDD (2.1) 20 mg/day in am (initial dose) 10 to 20 mg/day (initial dose) OCD (2.2) 20 mg/day in am (initial dose) 10 mg/day (initial dose) Bulimia Nervosa (2.3) 60 mg/day in am - Panic Disorder (2.4) 10 mg/day (initial dose) - Depressive Episodes Associated with Bipolar I Disorder (2.5) Oral in combination with olanzapine: 5 mg of oral olanzapine and 20 mg of fluoxetine once daily (initial dose) - Consider tapering the dose of fluoxetine for ...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50529,27447,'N/A',40.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 40 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50530,18062,'N/A',0.0,NULL,24,7,'مضادة للحساسية للاطفال -- مرطب للعين للاطفال','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50531,23084,'N/A',0.12,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.12 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50532,5185,'N/A',1.5,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 1.5 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50533,16245,'698AAA0A-9FD3-40C2-EC93-0DC2170A75BA',0.0,NULL,NULL,7,'Dosage and Administration A small amount of ointment placed in the lower conjunctival sac every three hours, or more frequently if deemed advisable by the prescribing physician. Administration should be continued day and night the first 48 hours, after which the interval between applications may be increased. Treatment should be continued for at least 48 hours after the eye appears normal.','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50534,14329,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50535,18579,'05813526-41d0-4451-8543-f4288ba7eb95',0.0,NULL,24,7,'DOSAGE AND ADMINISTRATION: Take 1-2 tablets daily, as a dietary supplement, as directed by your physician. HOW SUPPLIED: Nicotinamide Tablets are white-colored, oval-shaped tablets debossed on one side with “342”, and are supplied in bottles of 60 tablets (42192-374-60). The listed product number is not a National Drug Code. Instead, Acella has assigned a product code formatted according to standard industry practice in order to comply with the formatting requirements of pharmacy and healthcare ','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50536,6921,'45a7e3c2-8527-4447-90fe-07ce688f25d3',0.0,NULL,24,7,'DOSAGE AND ADMINISTRATION The dose is one drop of Dorzolamide HCl Ophthalmic Solution in the affected eye(s) three times daily. Dorzolamide HCl Ophthalmic Solution may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic drug is being used, the drugs should be administered at least ten minutes apart.','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50537,236,'N/A',10.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 10 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50538,6248,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50539,12685,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50540,4088,'ba17a773-7f7a-4cc5-9297-359decedfed0',220.0,NULL,24,7,'Standard Dose: 220.0mg. 2 DOSAGE AND ADMINISTRATION Administer ASMANEX TWISTHALER by the orally inhaled route only. Instruct patients to inhale rapidly and deeply. Advise patients to rinse the mouth after inhalation. Individual patients will experience a variable time to onset and degree of symptom relief. Maximum benefit may not be achieved for 1 to 2 weeks or longer after initiation of treatment. After asthma stability has been achieved, it is desirable to titrate to the lowest effective dosage to reduce the possibil...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50541,8578,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50542,33042,'55b99f22-9eb2-4df6-9979-bc4c3af5e454',70.0,NULL,24,7,'Standard Dose: 70.0mg. DOSAGE AND ADMINISTRATION Whether given with carbidopa-levodopa or with levodopa, the optimal daily dose of carbidopa must be determined by careful titration. Most patients respond to a 1:10 proportion of carbidopa-levodopa, provided the daily dosage of carbidopa is 70 mg or more a day. The maximum daily dosage of carbidopa should not exceed 200 mg, since clinical experience with larger dosages is limited. If the patient is taking carbidopa-levodopa, the amount of carbidopa in carbidopa-levodopa...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50543,28938,'d73a7aa3-5b5f-4532-9936-752366a2430d',160.0,320.0,24,7,'Standard Dose: 160.0mg. 2 DOSAGE AND ADMINISTRATION Indication Starting D ose Dose Range Target Maintenance Dose* Adult Hypertension (2.1) 80 or 160 mg once daily 80-320 mg once daily --- Pediatric Hypertension (6-16 years) (2.1) 1.3 mg/kg once daily (up to 40 mg total) 1.3-2.7 mg/kg once daily (up to 40-160 mg total) --- Heart Failure (2.2) 40 mg twice daily 40-160 mg twice daily 160 mg twice daily Post-Myocardial Infarction (2.3) 20 mg twice daily 20-160 mg twice daily 160 mg twice daily * as tolerated by patient No ...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50544,26149,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50545,28192,'c899b329-cc5e-4443-8e94-451314de47c9',0.0,NULL,24,7,'2 DOSAGE AND ADMINISTRATION Apply a pea-sized amount once daily to each of the five areas of the face: central forehead, chin, nose, each cheek. Brimonidine topical gel should be applied smoothly and evenly as a thin layer across the entire face avoiding the eyes and lips. Wash hands after applying brimonidine topical gel. Brimonidine topical gel is for topical use only and not for oral, ophthalmic, or intravaginal use. •Apply a pea-sized amount once daily to each of the five areas of the face (','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50546,25789,'N/A',2.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50547,14048,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50548,1417,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50549,13948,'ab23bc6e-b6a8-165f-e053-2a95a90ab144',5.0,NULL,NULL,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION The recommended dosage of BARHEMSYS: Prevention of PONV, either alone or in combination with another antiemetic: 5 mg as a single intravenous dose infused over 1 to 2 minutes at the time of induction of anesthesia. (2.1) Treatment of PONV: 10 mg as a single intravenous dose infused over 1 to 2 minutes in the event of nausea and/or vomiting after a surgical procedure. (2.1) See full prescribing information for preparation and administration instructions. (2.2) 2.1 Reco...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50550,3710,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50551,29559,'5f76e16f-0c24-454a-81af-4080b312c940',100.0,NULL,24,7,'Standard Dose: 100.0mg. 2 DOSAGE AND ADMINISTRATION •Assess renal function before initiating and as clinically indicated. Assess volume status and correct volume depletion before initiating ( 2.1). •The recommended starting dosage in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus is 100 mg orally once daily, taken before the first meal of the day to improve glycemic control. The dosage can be increased to 300 mg once daily in patients tolerating 100 mg once daily who have an eGFR of...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50552,28366,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50553,27888,'N/A',5.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 5 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50554,19054,'ab11dd8a-0fd9-4013-89ab-e114557c7e4b',240.0,NULL,NULL,7,'Standard Dose: 240.0mg. 2 DOSAGE AND ADMINISTRATION FIRMAGON is for subcutaneous use only Starting Dosage: 240 mg given as two injections of 120 mg each (2.1) Maintenance Dosage: 80 mg administered as a single injection every 28 days (2.1) 2.1 Dosing information FIRMAGON is administered as a subcutaneous injection in the abdominal region only at the dosages in Table 1 below. Table 1: FIRMAGON Recommended Dosages Starting Dosage Maintenance Dosage – Administered once every 28 days 240 mg given as two subcutaneous inject...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50555,24760,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50556,27303,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50557,19925,'N/A',2.4,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 2.4 mg (عن طريق الحقن). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50558,27066,'a912d27c-00cb-2ed0-effe-2d88d1f2ca67',2.0,NULL,24,7,'Standard Dose: 2.0mg. 2 DOSAGE AND ADMINISTRATION Intravenous use only. Daily dose should not exceed 2 g per kg body weight. (2.1) Indication Dose Hypovolemia Adults: 25 g (2.1) Children: (less than 13 years) 2.5 to 1.25 g (2.1) Hypoalbuminemia Adults: 50 to 75 g (2.1) Prevention of volume depletion after paracentesis Adults: 8 g for every 1,000 mL of ascitic fluid removed (2.1) Do not dilute with sterile water for injection as this may cause hemolysis in recipients. (5.6) Store protected from light. (16) Do not free...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50559,17433,'N/A',0.2,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50560,13627,'N/A',60.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 60 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50561,24988,'00a642fd-fbbc-41d8-ac62-83444f0b8284',0.0,NULL,NULL,7,'DIRECTIONS: USE AS DIRECTED. STOP USE IF REDNESS, IRRITATION, ITCHING AND/OR DARKENING OCCURS.','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50562,15396,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50563,4923,'a697e731-8d19-4845-8f31-16c4b19bb338',50.0,NULL,NULL,7,'Standard Dose: 50.0mg. DOSAGE AND ADMINISTRATION Carefully consider the potential benefits and risks of diclofenac potassium immediate-release tablets and other treatment options before deciding to use diclofenac potassium immediate-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). After observing the response to initial therapy with diclofenac potassium immediate-release tablets, the dose and frequency should be adjusted to suit...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50564,29042,'c1730a51-4383-4c61-a9a1-7e1326bd0abe',5.0,10.0,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION Adult recommended starting dose: 5 mg orally once daily with a maximum of 10 mg orally once daily. (2.1) Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg orally once daily. (2.1) Pediatric starting dose: 2.5 mg to 5 mg orally once daily. (2.2) 2.1 Adults The usual initial antihypertensive oral dose of NORLIQVA is 5 mg orally once daily, and the maximum dose is 10 mg orally once daily. Small, fragile, or elderly patie...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50565,27860,'ebddb745-81f9-4b25-8739-b2886032ed26',5.0,NULL,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION CIALIS for use as needed: Starting dose: 10 mg up to once daily. Increase to 20 mg or decrease to 5 mg based upon efficacy/tolerability. Improves erectile function compared to placebo up to 36 hours post dose (2.1). CIALIS for once daily use: 2.5 mg taken once daily, without regard to timing of sexual activity. May increase to 5 mg based upon efficacy and tolerability (2.1). CIALIS may be taken without regard to food (2.2). 2.1 Erectile Dysfunction CIALIS for Use as N...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50566,3469,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50567,5027,'EE2B4869-CD13-489B-B12F-1CE4FE081157',500.0,NULL,NULL,7,'Standard Dose: 500.0mg. DOSAGE AND ADMINISTRATION The recommended initial dose of Nascobal Nasal Spray is one spray (500 mcg) administered in ONE nostril once weekly. Nascobal Nasal Spray should be administered at least one hour before or one hour after ingestion of hot foods or liquids. Periodic monitoring of serum B12 levels should be obtained to establish adequacy of therapy.Before the first dose and administration, the pump must be primed. Remove the clear plastic cover and the plastic safety clip from the pump. To...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50568,32054,'E2CAAB63-1E0D-44E8-B9A8-BDFB59CE1288',0.1,NULL,24,7,'Standard Dose: 0.1mg. DOSAGE AND ADMINISTRATION Oral administration is preferred. Although most patients with malabsorption cannot absorb food folates, they are able to absorb folic acid given orally. Parenteral administration is not advocated but may be necessary in some individuals (e.g., patients receiving parenteral or enteral alimentation). Doses greater than 0.1 mg should not be used unless anemia due to vitamin B12 deficiency has been adequately treated with a cobalamin. Daily doses greater than 1 mg do not en...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50569,1914,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50570,23896,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50571,30422,'6906b0b4-1944-40f0-844a-e0db72ba4675',5.0,NULL,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION The recommended starting dose of memantine hydrochloride tablets is 5 mg once daily. The dose should be increased in 5 mg increments to 10 mg/day (5 mg twice daily), 15 mg/day (5 mg and 10 mg as separate doses), and 20 mg/day (10 mg twice daily). The minimum recommended interval between dose increases is one week. The dosage shown to be effective in controlled clinical trials is 20 mg/day. Memantine hydrochloride can be taken with or without food. If a patient misses ...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50572,33530,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50573,29644,'ec308fcf-ec39-43af-97e3-98aa8ab997f4',200.0,NULL,24,7,'Standard Dose: 200.0mg. DOSAGE AND ADMINISTRATION Adults The recommended starting dose of ketoconazole tablets is a single daily administration of 200 mg (one tablet). In very serious infections or if clinical responsiveness is insufficient within the expected time, the dose of ketoconazole may be increased to 400 mg (two tablets) once daily. Children In small numbers of children over 2 years of age, a single daily dose of 3.3 to 6.6 mg/kg has been used. Ketoconazole tablets have not been studied in children under 2 ye...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50574,27848,'N/A',0.0,NULL,24,7,'كريم مرطب للجلد __ يعمل علي ترطيب وتنعيم الجلد __ توحيد لون البشرة','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50575,16926,'e90f98d9-3c9b-4e75-ba18-5517283eadf0',5.0,NULL,12,7,'Standard Dose: 5.0mg. 2 DOSAGE & ADMINISTRATION ALINIA Tablets should not be administered to pediatric patient 11 years of age or younger ( 2.1) Dosage for treatment of diarrhea caused by G. lambliaor C. parvum( 2.1): Age Dosage Duration 1-3 years 5 mL of ALINIA for Oral Suspension (100 mg nitazoxanide) every 12 hours with food 4-11 years 10 mL of ALINIA for Oral Suspension (200 mg nitazoxanide) every 12 hours with food 3 days 12 years and older One ALINIA Tablet (500 mg nitazoxanide) every 12 hours with food or25 mL...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50576,17400,'N/A',1.4,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 1.4 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50577,2832,'N/A',0.3,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.3 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50578,15859,'N/A',0.25,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.25 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50579,20086,'N/A',0.0,NULL,24,7,'مكمل غذائي لزيادة الوزن','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50580,14273,'24d10449-2936-4cd3-b7db-a7683db721e4',260.0,NULL,NULL,7,'Standard Dose: 260.0mg. 2 DOSAGE AND ADMINISTRATION • Do not substitute ABRAXANE for other paclitaxel products. (2.1) • Extravasation: Closely monitor the infusion site for extravasation and infiltration. (2.1) • Metastatic Breast Cancer (MBC): Recommended dosage of ABRAXANE is 260 mg/m2 intravenously over 30 minutes every 3 weeks. (2. 2) • Non-Small Cell Lung Cancer (NSCLC): Recommended dosage of ABRAXANE is 100 mg/m2 intravenously over 30 minutes on Days 1, 8, and 15 of each 21-day cycle; administer carboplatin on Da...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50581,6004,'05813526-41d0-4451-8543-f4288ba7eb95',0.0,NULL,24,7,'DOSAGE AND ADMINISTRATION: Take 1-2 tablets daily, as a dietary supplement, as directed by your physician. HOW SUPPLIED: Nicotinamide Tablets are white-colored, oval-shaped tablets debossed on one side with “342”, and are supplied in bottles of 60 tablets (42192-374-60). The listed product number is not a National Drug Code. Instead, Acella has assigned a product code formatted according to standard industry practice in order to comply with the formatting requirements of pharmacy and healthcare ','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50582,19852,'aaadccea-4842-493b-a0bd-0ee7645fc250',100.0,NULL,24,7,'Standard Dose: 100.0mg. 2 DOSAGE AND ADMINISTRATION The recommended dose of JANUVIA is 100 mg once daily. JANUVIA can be taken with or without food. (2.1) Dosage adjustment is recommended for patients with moderate or severe renal insufficiency or end-stage renal disease. (2.2) Dosage Adjustment in Patients With Moderate, Severe and End Stage Renal Disease (ESRD) (2.2) 50 mg once daily 25 mg once daily Moderate CrCl ≥30 to <50 mL/min ~Serum Cr levels [mg/dL] Men: >1.7–≤3.0; Women: >1.5–≤2.5 Severe and ESRD CrCl <30 mL/...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50583,5870,'3c420b53-c95e-46af-aebd-73741be58391',0.0,NULL,NULL,7,'2 DOSAGE AND ADMINISTRATION Insert a single Paragard at the fundus of the uterine cavity. Remove Paragard no later than 10 years from the date of insertion. (2.1) Insert and remove Paragard only if you are a healthcare provider trained on these procedures. (2.1) See the Full Prescribing Information for recommended timing of insertion preparation instructions, insertion procedures, postplacement management, and instructions on removing Paragard. (2.2, 2.3, 2.4, 2.5, 2.6) Following the insertion, ','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50584,28377,'N/A',30.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 30 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50585,3026,'6d46258b-31d0-4e43-9acd-4c821f09ec0f',400.0,NULL,24,7,'Standard Dose: 400.0mg. DOSAGE AND ADMINISTRATION Epilepsy In the controlled add-on trials, no correlation has been demonstrated between trough plasma concentrations of topiramate and clinical efficacy. No evidence of tolerance has been demonstrated in humans. Doses above 400 mg/day (600, 800, or 1000 mg/day) have not been shown to improve responses in dose-response studies in adults with partial onset seizures. It is not necessary to monitor topiramate plasma concentrations to optimize topiramate therapy. On occasion,...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50586,10766,'N/A',0.0,NULL,24,7,'مضاد للتقلصات','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50587,13024,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50588,28084,'A0EEEC15-C76D-41DF-80F3-5572C9857DA6',5.0,NULL,24,7,'Standard Dose: 5.0mg. DOSAGE AND ADMINISTRATION The initial dosage of prednisolone tablets may vary from 5 mg to 60 mg per day depending on the specific disease entity being treated. In situations of less severity, lower doses will generally suffice, while in selected patients higher initial doses may be required. The initial dosage should be maintained or adjusted until a satisfactory response is noted. If after a reasonable period of time there is a lack of satisfactory clinical response, prednisolone should be dis...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50589,28726,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50590,30822,'A4FD2D68-019F-4C89-8923-4E61262F6EEE',25.0,NULL,NULL,7,'Standard Dose: 25.0mg. DOSAGE AND ADMINISTRATION Diclofenac sodium may be administered as 25 mg, 50 mg, or 75 mg delayed-release tablets. Regardless of the indication, the dosage of diclofenac should be individualized to the lowest effective dose to minimize adverse effects (see CLINICAL PHARMACOLOGY: Individualization of Dosage) Osteoarthritis: The recommended dosage is 100 to 150 mg/day in divided doses, 50 mg b.i.d. or t.i.d. or 75 mg b.i.d. Dosages above 150 mg/day have not been studied in patients with osteoarthr...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50591,29677,'N/A',0.0,NULL,24,7,'مسكن عام للالام -- علاج الروماتيزم -- علاج التهاب المفاصل والعظام -- الحفاظ علي السائل الغضروفي','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50592,26311,'325a5d0e-9a72-4015-9fcd-1655fb504cee',20.0,NULL,24,7,'Standard Dose: 20.0mg. 2 DOSAGE AND ADMINISTRATION Take orally with or without food, at any time of day. (2.1) Assess LDL-C when clinically appropriate, as early as 4 weeks after initiating CRESTOR, and adjust dosage if necessary. (2.1) Adults: Recommended dosage range is 5 to 40 mg once daily. (2.1) Pediatric Patients with HeFH: Recommended dosage range is 5 to 10 mg once daily for patients aged 8 to less than 10 years of age, and 5 to 20 mg once daily for patients aged 10 years and older. (2.2) Pediatric Patients wi...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50593,4242,'N/A',0.0,NULL,24,7,'دعم وظائف الادراك في الدماغ والجهاز العصبي','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50594,18629,'d8b55a7c-4d05-08b0-e053-2995a90ae42c',45.0,NULL,NULL,7,'Standard Dose: 45.0mg. DOSAGE AND ADMINISTRATION The recommended dose is 45 mg/m 2/day administered as two evenly divided doses until complete remission is documented. Therapy should be discontinued 30 days after achievement of complete remission or after 90 days of treatment, whichever occurs first. If after initiation of treatment of tretinoin the presence of the t(15;17) translocation is not confirmed by cytogenetics and/or by polymerase chain reaction studies and the patient has not responded to tretinoin, alterna...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50595,28779,'aec9984e-34c5-481b-b6bf-9bb5caf1daf8',20.0,NULL,24,7,'Standard Dose: 20.0mg. 2 DOSAGE AND ADMINISTRATION •Use another formulation of methotrexate for patients requiring dosing via routes of administration other than oral (2.1). •Measure with an accurate measuring device (2.1). Recommended Dosage: •ALL: 20 mg/m2 one time weekly (2.2). •pJIA: Starting dose of 10 mg/m2 one time weekly (2.3). 2.1 Important Administration Information XATMEP is intended for oral use only. Use another formulation of methotrexate for alternative dosing in patients who require dosing via other ro...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50596,21409,'N/A',0.0,NULL,24,7,'غسول منظف للوجه','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50597,3491,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50598,23119,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50599,15790,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50600,7893,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50601,31287,'7e41818c-60e9-4bcf-9586-7bb8d33d5e89',500.0,2000.0,24,7,'Standard Dose: 500.0mg. 2 DOSAGE AND ADMINISTRATION •Swallow metformin hydrochloride extended-release tablets whole and never crush, cut or chew (2.1) •Starting dose: 500 mg orally once daily with the evening meal (2.1) •Increase the dose in increments of 500 mg weekly, up to a maximum of 2000 mg once daily with the evening meal (2.1) •Patients receiving metformin hydrochloride (HCl) tablets may be switched to metformin hydrochloride extended-release tablets once daily at the same total daily dose, up to 2000 mg once d...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50602,13754,'c1730a51-4383-4c61-a9a1-7e1326bd0abe',5.0,10.0,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION Adult recommended starting dose: 5 mg orally once daily with a maximum of 10 mg orally once daily. (2.1) Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg orally once daily. (2.1) Pediatric starting dose: 2.5 mg to 5 mg orally once daily. (2.2) 2.1 Adults The usual initial antihypertensive oral dose of NORLIQVA is 5 mg orally once daily, and the maximum dose is 10 mg orally once daily. Small, fragile, or elderly patie...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50603,23760,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50604,19248,'N/A',0.2,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50605,13182,'cb18564f-663f-4da2-9dd9-700ea9bdd398',10.0,NULL,24,7,'Standard Dose: 10.0mg. 2 DOSAGE AND ADMINISTRATION 2.1 General Dosing InformationThe recommended dose of ZETIA is 10 mg once daily. ZETIA can be administered with or without food. 2.2 Concomitant Lipid-Lowering TherapyZETIA may be administered with a statin (in patients with primary hyperlipidemia) or with fenofibrate (in patients with mixed hyperlipidemia) for incremental effect. For convenience, the daily dose of ZETIA may be taken at the same time as the statin or fenofibrate, according to the dosing recommendation...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50606,29349,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50607,30470,'N/A',7.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 7 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50608,19960,'N/A',0.1,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.1 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50609,16308,'698AAA0A-9FD3-40C2-EC93-0DC2170A75BA',0.0,NULL,NULL,7,'Dosage and Administration A small amount of ointment placed in the lower conjunctival sac every three hours, or more frequently if deemed advisable by the prescribing physician. Administration should be continued day and night the first 48 hours, after which the interval between applications may be increased. Treatment should be continued for at least 48 hours after the eye appears normal.','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50610,24841,'218fba79-c773-482d-90aa-7cf678694c36',0.0,NULL,24,7,'2 DOSAGE AND ADMINISTRATION Patients 1 year of age or older: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times on Day 1. Instill one drop two to four times daily in the affected eye(s) while awake on Days 2 through 7. Patients 1 year of age or older: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times on Day 1. Instill one drop two to four times daily in the affected eye(s) while awake on Days 2 through 7. (2)','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50611,13434,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50612,14777,'N/A',0.0,NULL,24,7,'علاج التهاب المفاصل','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50613,1900,'94a59260-d2b6-464a-b5b9-bbc599e57e10',16.0,NULL,24,7,'Standard Dose: 16.0mg. 2 DOSAGE AND ADMINISTRATION Starting Dose Target Dose Adult Hypertension (2.1) 16 mg tablet once daily 8 – 32 mg tablet total daily dose Pediatric Hypertension (1 to < 6 years) (2.2) 0.20 mg/kg oral suspension once daily 0.05 – 0.4 mg/kg oral suspension once daily or consider divided dose Pediatric Hypertension (6 to < 17 years) (2.2) < 50 kg 4 – 8 mg tablet once daily >50 kg 8 – 16 mg tablet once daily < 50 kg 4 – 16 mg tablet once daily or consider divided dose > 50 kg 4 – 32 mg tablet once da...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50614,30335,'2bd238d4-4657-4341-9c28-1b468b8f3bf8',20.0,NULL,24,7,'Standard Dose: 20.0mg. DOSAGE AND ADMINISTRATION Prior to initiation of caffeine citrate, baseline serum levels of caffeine should be measured in infants previously treated with theophylline, since preterm infants metabolize theophylline to caffeine. Likewise, baseline serum levels of caffeine should be measured in infants born to mothers who consumed caffeine prior to delivery, since caffeine readily crosses the placenta. The recommended loading dose and maintenance doses of caffeine citrate follow. Dose of caffeine ...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50615,12570,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50616,13110,'EE2B4869-CD13-489B-B12F-1CE4FE081157',500.0,NULL,NULL,7,'Standard Dose: 500.0mg. DOSAGE AND ADMINISTRATION The recommended initial dose of Nascobal Nasal Spray is one spray (500 mcg) administered in ONE nostril once weekly. Nascobal Nasal Spray should be administered at least one hour before or one hour after ingestion of hot foods or liquids. Periodic monitoring of serum B12 levels should be obtained to establish adequacy of therapy.Before the first dose and administration, the pump must be primed. Remove the clear plastic cover and the plastic safety clip from the pump. To...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50617,15424,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50618,15839,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50619,33026,'N/A',7.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 7 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50620,24489,'N/A',0.2,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.2 g (عن طريق المهبل). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50621,24649,'N/A',0.4,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.4 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50622,24762,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50623,11380,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50624,22796,'56bf1b0a-463a-4324-957b-585d4cf352ee',7.5,NULL,24,7,'Standard Dose: 7.5mg. DOSAGE AND ADMINISTRATION Hypertension The recommended initial dose of moexipril hydrochloride in patients not receiving diuretics is 7.5 mg, one hour prior to meals, once daily. Dosage should be adjusted according to blood pressure response. The antihypertensive effect of moexipril hydrochloride may diminish towards the end of the dosing interval. Blood pressure should, therefore, be measured just prior to dosing to determine whether satisfactory blood pressure control is obtained. If control i...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50625,28492,'A9987047-9C99-45A5-829B-AE8B189CBFD4',250.0,NULL,24,7,'Standard Dose: 250.0mg. DOSAGE AND ADMINISTRATION In elderly patients, the pharmacokinetics of metronidazole may be altered, and, therefore, monitoring of serum levels may be necessary to adjust the metronidazole dosage accordingly. Trichomoniasis In the Female One-day treatment— two grams of metronidazole, given either as a single dose or in two divided doses of one gram each given in the same day.Seven-day course of treatment— 250 mg three times daily for seven consecutive days. There is some indication from controll...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50626,13432,'4423d70a-b120-4653-bcf3-0c5ea8b97b0e',30.0,NULL,24,7,'Standard Dose: 30.0mg. 2 DOSAGE AND ADMINISTRATION ACTONEL should be taken at least 30 minutes before the first food or drink of the day other than water. To facilitate delivery to the stomach, ACTONEL should be swallowed while the patient is in an upright position and with a full glass of plain water (6 to 8 oz). Patients should not lie down for 30 minutes after taking the medication [see Warnings and Precautions (5.1)]. Patients should receive supplemental calcium and vitamin D if dietary intake is inadequate [see W...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50627,20848,'d3e5fbbf-4a1f-4aa2-8e80-9729f6cf04ee',0.0,NULL,24,7,'DOSAGE AND ADMINISTRATION All patients should be evaluated for bleeding disorders before administration of INNOHEP®. Since coagulation parameters are unsuitable for monitoring INNOHEP® activity, routine monitoring of coagulation parameters is not required (see PRECAUTIONS, Laboratory Tests). Adult Dosage The recommended dose of INNOHEP® for the treatment of DVT with or without PE is 175 anti-Xa IU/kg of body weight, administered SC once daily for at least 6 days and until the patient is adequate','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50628,15995,'1781fc07-5a2a-4b31-aad9-d0457eb704f4',250.0,NULL,24,7,'Standard Dose: 250.0mg. DOSAGE AND ADMINISTRATION Ceftriaxone for injection may be administered intravenously or intramuscularly. Do not use diluents containing calcium, such as Ringer''s solution or Hartmann''s solution, to reconstitute ceftriaxone for injection vials or to further dilute a reconstituted vial for IV administration because a precipitate can form. Precipitation of ceftriaxone-calcium can also occur when ceftriaxone for injection is mixed with calcium-containing solutions in the same IV administration line...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50629,25387,'bd637448-fc45-466d-af90-20e1560bc293',1.0,NULL,24,7,'Standard Dose: 1.0mg. DOSAGE AND ADMINISTRATION DOSAGE MUST BE INDIVIDUALIZED. The initial dosage of doxazosin tablets in patients with hypertension and/or BPH is 1 mg given once daily in the a.m. or p.m. This starting dose is intended to minimize the frequency of postural hypotension and first dose syncope associated with doxazosin. Postural effects are most likely to occur between 2 and 6 hours after a dose. Therefore blood pressure measurements should be taken during this time period after the first dose and with ...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50630,30134,'N/A',0.0,NULL,24,7,'مكمل غذائى يستخدم لدعم الجهاز المناعي ويساعد على تخفيف أعراض التهابات الجهاز التنفسي العلوي مثل نزلات البرد','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50631,9393,'N/A',0.0,NULL,24,7,'مسكن ومضاد للالتهابات ويستخدم لزيادة ليونة الانسجة والمفاصل','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50632,6545,'8de6a6eb-9ed8-4e05-9a4c-d657b5634f76',12.0,6.0,24,7,'Standard Dose: 12.0mg. 2 DOSAGE AND ADMINISTRATION For schizophrenia: 6 mg extended-release tablet administered in the morning with or without food. Initial dose titration is not required. Some patients may benefit from either higher doses up to 12 mg/day, or a lower dose of 3 mg/day. If clinical assessment warrants, increase the dose at increments of 3 mg/day at intervals of more than 5 days. Maximum recommended dose is 12 mg/day. (2.1) For schizoaffective disorder: 6 mg extended-release tablet administered in the mo...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50633,5960,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50634,5509,'N/A',0.45,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.45 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50635,5236,'7b38ac8a-4540-4eb2-aedd-9aa966d22190',100.0,NULL,24,7,'Standard Dose: 100.0mg. DOSAGE AND ADMINISTRATION Therapy should be individualized according to patient response. Use the smallest dosage necessary to achieve the required response. Adults For EdemaThe usual adult dosage is 25 to 100 mg daily as a single or divided dose. Many patients with edema respond to intermittent therapy, i.e., administration on alternate days or on three to five days each week. With an intermittent schedule, excessive response and the resulting undesirable electrolyte imbalance are less likely t...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50636,6969,'e176b6ef-2ff6-498b-a9d8-7a634d147f37',360.0,NULL,NULL,7,'Standard Dose: 360.0mg. DOSAGE AND ADMINISTRATION NOTE: Aluminum reacts with carboplatin causing precipitate formation and loss of potency, therefore, needles or intravenous sets containing aluminum parts that may come in contact with the drug must not be used for the preparation or administration of carboplatin injection. Single Agent Therapy Carboplatin injection, as a single agent, has been shown to be effective in patients with recurrent ovarian carcinoma at a dosage of 360 mg/m2 IV on day 1 every 4 weeks (alternat...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50637,12923,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50638,24618,'2bd238d4-4657-4341-9c28-1b468b8f3bf8',20.0,NULL,24,7,'Standard Dose: 20.0mg. DOSAGE AND ADMINISTRATION Prior to initiation of caffeine citrate, baseline serum levels of caffeine should be measured in infants previously treated with theophylline, since preterm infants metabolize theophylline to caffeine. Likewise, baseline serum levels of caffeine should be measured in infants born to mothers who consumed caffeine prior to delivery, since caffeine readily crosses the placenta. The recommended loading dose and maintenance doses of caffeine citrate follow. Dose of caffeine ...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50639,23242,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50640,25871,'7efed863-919d-458e-99e1-ce0cec95537a',5.0,40.0,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION Hypertension Adult: recommended initial dose is 5 mg once daily. Maximum dose is 40 mg daily (2.1). Pediatrics: recommended starting dose is 0.08 mg/kg (up to 5 mg) once daily (2.1). Heart Failure: Initiate at 2.5 mg twice daily. Titrate up to 20 mg twice daily as tolerated (2.2). Asymptomatic Left Ventricular Dysfunction: Initiate at 2.5 mg twice daily. Titrate up to 10 mg twice daily (2.3). Enalapril maleate oral solution is a ready-to-use solution intended for oral...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50641,15747,'94a59260-d2b6-464a-b5b9-bbc599e57e10',16.0,NULL,24,7,'Standard Dose: 16.0mg. 2 DOSAGE AND ADMINISTRATION Starting Dose Target Dose Adult Hypertension (2.1) 16 mg tablet once daily 8 – 32 mg tablet total daily dose Pediatric Hypertension (1 to < 6 years) (2.2) 0.20 mg/kg oral suspension once daily 0.05 – 0.4 mg/kg oral suspension once daily or consider divided dose Pediatric Hypertension (6 to < 17 years) (2.2) < 50 kg 4 – 8 mg tablet once daily >50 kg 8 – 16 mg tablet once daily < 50 kg 4 – 16 mg tablet once daily or consider divided dose > 50 kg 4 – 32 mg tablet once da...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50642,27905,'5d97f401-4853-4a9a-907d-21e8a4d16088',150.0,450.0,24,7,'Standard Dose: 150.0mg. 2 DOSAGE AND ADMINISTRATION NSCLC: 150 mg orally, on an empty stomach, once daily (2.2) Pancreatic cancer: 100 mg orally, on an empty stomach, once daily (2.3) 2.1 Selection of Patients with Metastatic NSCLC Select patients for the treatment of metastatic NSCLC with erlotinib tablets based on the presence of EGFR exon 19 deletions or exon 21 (L858R) substitution mutations in tumor or plasma specimens [See Clinical Studies (14.1, 14.2)]. If these mutations are not detected in a plasma specimen, t...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50643,7283,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50644,18410,'A4FD2D68-019F-4C89-8923-4E61262F6EEE',25.0,NULL,NULL,7,'Standard Dose: 25.0mg. DOSAGE AND ADMINISTRATION Diclofenac sodium may be administered as 25 mg, 50 mg, or 75 mg delayed-release tablets. Regardless of the indication, the dosage of diclofenac should be individualized to the lowest effective dose to minimize adverse effects (see CLINICAL PHARMACOLOGY: Individualization of Dosage) Osteoarthritis: The recommended dosage is 100 to 150 mg/day in divided doses, 50 mg b.i.d. or t.i.d. or 75 mg b.i.d. Dosages above 150 mg/day have not been studied in patients with osteoarthr...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50645,20129,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50646,2640,'6f41228b-974a-443b-a313-2fbb3d845915',250.0,400.0,12,7,'Standard Dose: 250.0mg. DOSAGE AND ADMINISTRATION Adults Ciprofloxacin tablets should be administered orally to adults as described in the Dosage Guidelines table. The determination of dosage for any particular patient must take into consideration the severity and nature of the infection, the susceptibility of the causative organism, the integrity of the patient''s host-defense mechanisms, and the status of renal function and hepatic function. The duration of treatment depends upon the severity of infection. The usual d...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50647,6568,'029a90b6-0722-49be-8400-3ec29526aafd',300.0,300.0,24,7,'Standard Dose: 300.0mg. 2 DOSAGE AND ADMINISTRATION Indication Dose Hypertension ( 2.2) 150 to 300 mg once daily Diabetic Nephropathy ( 2.3) 300 mg once daily 2.1 General Considerations Irbesartan tablets may be administered with other antihypertensive agents and with or without food. 2.2 Hypertension The recommended initial dose of irbesartan tablets is 150 mg once daily. The dosage can be increased to a maximum dose of 300 mg once daily as needed to control blood pressure [see Clinical Studies (14.1)]. 2.3 Nephropath...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50648,2501,'N/A',30.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 30 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50649,18649,'N/A',0.11,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.11 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50650,33431,'E2CAAB63-1E0D-44E8-B9A8-BDFB59CE1288',0.1,NULL,24,7,'Standard Dose: 0.1mg. DOSAGE AND ADMINISTRATION Oral administration is preferred. Although most patients with malabsorption cannot absorb food folates, they are able to absorb folic acid given orally. Parenteral administration is not advocated but may be necessary in some individuals (e.g., patients receiving parenteral or enteral alimentation). Doses greater than 0.1 mg should not be used unless anemia due to vitamin B12 deficiency has been adequately treated with a cobalamin. Daily doses greater than 1 mg do not en...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50651,6664,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50652,28255,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50653,605,'N/A',3.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3.6 mg (عن طريق الحقن). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50654,22507,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50655,33894,'N/A',0.16,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.16 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50656,25846,'8eaee9bf-91c7-484b-b8b1-b8242198181f',110.0,NULL,24,7,'Standard Dose: 110.0mg. 2 DOSAGE AND ADMINISTRATION Administer VERAMYST Nasal Spray by the intranasal route only. Prime VERAMYST Nasal Spray before using for the first time by shaking the contents well and releasing 6 sprays into the air away from the face. When VERAMYST Nasal Spray has not been used for more than 30 days or if the cap has been left off the bottle for 5 days or longer, prime the pump again until a fine mist appears. Shake VERAMYST Nasal Spray well before each use. For intranasal use only. Usual startin...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50657,8828,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50658,3978,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50659,28175,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50660,14269,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50661,3181,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50662,31299,'N/A',3.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50663,26823,'N/A',16.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 16 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50664,31871,'N/A',7.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 7 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50665,32224,'N/A',3.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50666,8279,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50667,11724,'N/A',0.2,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50668,9728,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50669,18673,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50670,14498,'N/A',1.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 1 tablet (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50671,2631,'6f41228b-974a-443b-a313-2fbb3d845915',250.0,400.0,12,7,'Standard Dose: 250.0mg. DOSAGE AND ADMINISTRATION Adults Ciprofloxacin tablets should be administered orally to adults as described in the Dosage Guidelines table. The determination of dosage for any particular patient must take into consideration the severity and nature of the infection, the susceptibility of the causative organism, the integrity of the patient''s host-defense mechanisms, and the status of renal function and hepatic function. The duration of treatment depends upon the severity of infection. The usual d...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50672,9496,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50673,7692,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50674,3357,'A4FD2D68-019F-4C89-8923-4E61262F6EEE',25.0,NULL,NULL,7,'Standard Dose: 25.0mg. DOSAGE AND ADMINISTRATION Diclofenac sodium may be administered as 25 mg, 50 mg, or 75 mg delayed-release tablets. Regardless of the indication, the dosage of diclofenac should be individualized to the lowest effective dose to minimize adverse effects (see CLINICAL PHARMACOLOGY: Individualization of Dosage) Osteoarthritis: The recommended dosage is 100 to 150 mg/day in divided doses, 50 mg b.i.d. or t.i.d. or 75 mg b.i.d. Dosages above 150 mg/day have not been studied in patients with osteoarthr...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50675,30845,'90bf8e28-748d-4e4b-a19f-9cf483370eff',10.0,NULL,24,7,'Standard Dose: 10.0mg. 2 DOSAGE AND ADMINISTRATION •Recommended starting dose is 10 g administered three times a day for up to 48 hours. (2.1) •For maintenance treatment, recommended dose is 10 g once daily. Adjust dose at one-week intervals as needed (by 5 g daily) to obtain desired serum potassium target range. (2.1) Patients on Chronic Hemodialysis •Recommended starting dose is 5 g once daily on non-dialysis days. (2.2) See full Prescribing Information for additional dosing instructions, as well as reconstitution a...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50676,8066,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50677,2624,'6f41228b-974a-443b-a313-2fbb3d845915',250.0,400.0,12,7,'Standard Dose: 250.0mg. DOSAGE AND ADMINISTRATION Adults Ciprofloxacin tablets should be administered orally to adults as described in the Dosage Guidelines table. The determination of dosage for any particular patient must take into consideration the severity and nature of the infection, the susceptibility of the causative organism, the integrity of the patient''s host-defense mechanisms, and the status of renal function and hepatic function. The duration of treatment depends upon the severity of infection. The usual d...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50678,22918,'dc2427ff-e566-4b48-b289-9e51c011250a',50.0,NULL,24,7,'Standard Dose: 50.0mg. 2 DOSAGE & ADMINISTRATION Application of one ORAVIG 50 mg buccal tablet to the gum region once daily for 14 consecutive days (2.1). Instruct patients not to crush, chew, or swallow tablets (2.2). 2.1 Basic Dosing Information The recommended dosing schedule for ORAVIG is the application of one 50 mg buccal tablet to the upper gum region (canine fossa) once daily for 14 consecutive days. 2.2 Administration Instructions ORAVIG should be applied in the morning, after brushing the teeth. The tablet s...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50679,28824,'e433dc68-6b2a-4c48-beae-4ec946f1ff1e',5.0,NULL,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION 5 mg tablet taken once daily, and if well tolerated may be increased to 10 mg once daily (2.1) Do not exceed 5 mg tablet once daily in patients with: severe renal impairment [Creatinine Clearance] (CLcr <30 ml/min) (2.1) moderate hepatic impairment (Child-Pugh B) (2.2) concomitant use of potent CYP3A4 inhibitors (2.3) Use of VESIcare is not recommended in patients with severe hepatic impairment (Child-Pugh C) (2.2) 2.1 Dosing Information The recommended dose of VESIca...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50680,30709,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50681,20256,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50682,13005,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50683,13615,'N/A',0.5,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.5 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50684,8220,'N/A',30.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 30 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50685,23364,'N/A',3.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50686,20562,'N/A',40.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 40 U (عن طريق الحقن). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50687,28463,'1781fc07-5a2a-4b31-aad9-d0457eb704f4',250.0,NULL,24,7,'Standard Dose: 250.0mg. DOSAGE AND ADMINISTRATION Ceftriaxone for injection may be administered intravenously or intramuscularly. Do not use diluents containing calcium, such as Ringer''s solution or Hartmann''s solution, to reconstitute ceftriaxone for injection vials or to further dilute a reconstituted vial for IV administration because a precipitate can form. Precipitation of ceftriaxone-calcium can also occur when ceftriaxone for injection is mixed with calcium-containing solutions in the same IV administration line...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50688,16816,'8b59207a-ea5c-4697-a8b6-94c3015a00de',1.25,NULL,24,7,'Standard Dose: 1.25mg. DOSAGE AND ADMINISTRATION Blood pressure decreases associated with any dose of ramipril depend, in part, on the presence or absence of volume depletion (e.g., past and current diuretic use) or the presence or absence of renal artery stenosis. If such circumstances are suspected to be present, the initial starting dose should be 1.25 mg once daily. Hypertension The recommended initial dose for patients not receiving a diuretic is 2.5 mg once a day. Dosage should be adjusted according to the blood...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50689,20930,'9ce9adc8-6fa2-4444-8386-14cd576ac63d',20.0,300.0,24,7,'Standard Dose: 20.0mg. DOSAGE AND ADMINISTRATION – (NOT FOR PARENTERAL USE) Serum concentrations should be monitored and care should be taken when switching a patient from the sodium salt to the free acid form. The free acid form of phenytoin is used in Phenytoin Oral Suspension. Because there is approximately an 8% increase in drug content with the free acid form over that of the sodium salt, dosage adjustments and serum level monitoring may be necessary when switching from a product formulated with the free acid to ...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50690,20456,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50691,6025,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50692,16664,'N/A',0.3,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.3 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50693,23223,'8f5a8af6-ffbd-42ba-9313-083db14966fe',10.0,NULL,24,7,'Standard Dose: 10.0mg. DOSAGE AND ADMINISTRATION Important Dosage and Administration Instructions Nalbuphine Hydrochloride Injection should be administered as a supplement to general anesthesia only by persons specifically trained in the use of intravenous anesthetics and management of the respiratory effects of potent opioids. Naloxone, resuscitative and intubation equipment and oxygen should be readily available. Use the lowest effective dosage for the shortest duration of time ‎consistent with individual patient tr...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50694,6475,'9d3e528b-a748-4bc5-b604-e7e9c5ab9183',20.0,NULL,24,7,'Standard Dose: 20.0mg. DOSAGE AND ADMINISTRATION Carefully consider the potential benefits and risks of piroxicam capsules and other treatment options before deciding to use piroxicam capsules. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). After observing the response to initial therapy with piroxicam capsules, the dose and frequency should be adjusted to suit an individual patient''s needs. For the relief of rheumatoid arthritis and osteoarth...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50695,15326,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50696,622,'N/A',60.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 60 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50697,4988,'de8990a6-f3b6-478f-acbe-eda961b6da4b',500.0,NULL,24,7,'Standard Dose: 500.0mg. DOSAGE AND ADMINISTRATION Amoxicillin capsules may be given without regard to meals. However, food effect studies have not been performed with the 500 mg formulation. Neonates and infants aged ≤ 12 weeks (≤ 3 months): Due to incompletely developed renal function affecting elimination of amoxicillin in this age group, the recommended upper dose of amoxicillin is 30 mg/kg/day divided q12h.Adults and pediatric patients >3 months: * Dosing for infections caused by less susceptible organisms should f...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50698,14850,'N/A',0.0,NULL,24,7,'diaper rash','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50699,10649,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50700,24834,'N/A',0.0,NULL,24,7,'تونر يوضع بعد الغسول لتفتيح الجلد -- ينصح باستخدام نفس نوع الغسول لاعطاء افضل النتائج -- غلق المسام','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50701,10672,'f5bb0854-a477-4e59-914b-eeeaef92a596',100.0,NULL,NULL,7,'Standard Dose: 100.0mg. DOSAGE AND ADMINISTRATION Because of possible physical incompatibilities, SOLU-CORTEF should not be diluted or mixed with other solutions. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. This preparation may be administered by intravenous injection, by intravenous infusion, or by intramuscular injection, the preferred method for initial emergency use being intravenous injection. Follow...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50702,29940,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50703,7116,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50704,19383,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50705,12911,'5e2dbda9-aceb-4bfb-9c3f-e7b6118f580c',16.0,NULL,24,7,'Standard Dose: 16.0mg. DOSAGE AND ADMINISTRATION Instructions for Use/Handling ondansetron orally disintegrating tablets:Do not attempt to push ondansetron orally disintegrating tablets through the foil backing. With dry hands, PEEL BACK the foil backing of 1 blister and GENTLY remove the tablet. IMMEDIATELY place the ondansetron orally disintegrating tablet on top of the tongue where it will dissolve in seconds, then swallow with saliva. Administration with liquid is not necessary. Prevention of Nausea and Vomiting A...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50706,5734,'dfe327e8-f6ab-41e5-bdef-d520118cd83a',5.0,NULL,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION •The recommended dosage of TRADJENTA is 5 mg orally once daily (2.1) •TRADJENTA can be taken with or without food (2.1) 2.1 Recommended Dosage and Administration The recommended dosage of TRADJENTA is 5 mg taken orally once daily, with or without food....','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50707,29420,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50708,30604,'060bcf13-ce9e-488c-ad43-9d66abb23b18',40.0,NULL,24,7,'Standard Dose: 40.0mg. DOSAGE AND ADMINISTRATION NOTE: Methylprednisolone Sodium Succinate for Injection contains benzyl alcohol (see DESCRIPTION, WARNINGS and PRECAUTIONS, Pediatric Use). Because of the possible physical incompatibilities, Methylprednisolone Sodium Succinate for Injection should not be diluted or mixed with other solutions. Use only the Bacteriostatic Water For Injection with Benzyl Alcohol when reconstituting Methylprednisolone Sodium Succinate (see DESCRIPTION ). Use within 48 hours after mixing. P...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50709,31359,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50710,28475,'c1730a51-4383-4c61-a9a1-7e1326bd0abe',5.0,10.0,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION Adult recommended starting dose: 5 mg orally once daily with a maximum of 10 mg orally once daily. (2.1) Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg orally once daily. (2.1) Pediatric starting dose: 2.5 mg to 5 mg orally once daily. (2.2) 2.1 Adults The usual initial antihypertensive oral dose of NORLIQVA is 5 mg orally once daily, and the maximum dose is 10 mg orally once daily. Small, fragile, or elderly patie...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50711,14497,'N/A',3.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50712,14629,'de8990a6-f3b6-478f-acbe-eda961b6da4b',500.0,NULL,24,7,'Standard Dose: 500.0mg. DOSAGE AND ADMINISTRATION Amoxicillin capsules may be given without regard to meals. However, food effect studies have not been performed with the 500 mg formulation. Neonates and infants aged ≤ 12 weeks (≤ 3 months): Due to incompletely developed renal function affecting elimination of amoxicillin in this age group, the recommended upper dose of amoxicillin is 30 mg/kg/day divided q12h.Adults and pediatric patients >3 months: * Dosing for infections caused by less susceptible organisms should f...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50713,12123,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50714,27381,'N/A',0.4,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.4 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50715,4354,'9daa1483-5a36-44db-9e0d-904d100da262',15.0,NULL,24,7,'Standard Dose: 15.0mg. 2 DOSAGE AND ADMINISTRATION Indication Dose Frequency Short-Term Treatment of Erosive Esophagitis Associated With GERD ( 2.1) Adults 40 mg Once Daily for up to 8 wks Children (5 years and older) ≥ 15 kg to < 40 kg 20 mg Once Daily for up to 8 wks ≥ 40 kg 40 mg Maintenance of Healing of Erosive Esophagitis ( 2.1) Adults 40 mg Once Daily* Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome ( 2.1) Adults 40 mg Twice Daily * Controlled studies did not extend beyond 12 months ...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50716,18235,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50717,33272,'52fe0332-388a-451c-b759-97e760883837',0.0,NULL,24,7,'2 DOSAGE AND ADMINISTRATION Enter section text here One drop of NEVANAC® ophthalmic suspension should be applied to the affected eye(s) three-times-daily beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the postoperative period. ( 2 ) 2.1 Recommended Dosing One drop of NEVANAC ® should be applied to the affected eye(s) three-times-daily beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 wee','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50718,14227,'f60a672d-8d6d-4d67-9a47-5547357e7b5b',20.0,NULL,24,7,'Standard Dose: 20.0mg. 2 DOSAGE AND ADMINISTRATION Dose range: 10 to 80 mg once daily (2.1). Recommended start dose: 10 or 20 mg once daily (2.1). Patients requiring large LDL-C reduction (>45%) may start at 40 mg once daily (2.1). Pediatric starting dose: 10 mg once daily; maximum recommended dose: 20 mg once daily (2.2). 2.1 Hyperlipidemia (Heterozygous Familial and Nonfamilial) and Mixed Dyslipidemia (Fredrickson Types IIa and IIb) The recommended starting dose of LIPITOR is 10 or 20 mg once daily. Patients who req...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50719,29858,'N/A',12.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 12 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50720,3571,'0478f0e7-87fb-4adb-ae9b-6624555ccbe4',15.0,45.0,24,7,'Standard Dose: 15.0mg. 2 DOSAGE AND ADMINISTRATION •Initiate pioglitazone tablets at 15 mg or 30 mg once daily. Limit initial dose to 15 mg once daily in patients with NYHA Class I or II heart failure. (2.1) •If there is inadequate glycemic control, the dose can be increased in 15 mg increments up to a maximum of 45 mg once daily. (2.1) •The maximum recommended dose of pioglitazone tablets is 15 mg once daily in patients taking strong CYP2C8 inhibitors (e.g., gemfibrozil). (2.3, 7.1) •Obtain liver tests before startin...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50721,9214,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50722,1560,'N/A',0.0,NULL,24,7,'مكمل غذائي لتحسين المناعة والحيوية','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50723,23738,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50724,12251,'2bd238d4-4657-4341-9c28-1b468b8f3bf8',20.0,NULL,24,7,'Standard Dose: 20.0mg. DOSAGE AND ADMINISTRATION Prior to initiation of caffeine citrate, baseline serum levels of caffeine should be measured in infants previously treated with theophylline, since preterm infants metabolize theophylline to caffeine. Likewise, baseline serum levels of caffeine should be measured in infants born to mothers who consumed caffeine prior to delivery, since caffeine readily crosses the placenta. The recommended loading dose and maintenance doses of caffeine citrate follow. Dose of caffeine ...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50725,20268,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50726,14684,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50727,24322,'88218156-081a-4809-8143-f97bdab194ba',4.0,NULL,24,7,'Standard Dose: 4.0mg. DOSAGE AND ADMINISTRATION THE RANGE BETWEEN THERAPEUTIC AND TOXIC DOSES IS NARROW. Vitamin D Resistant Rickets: 12,000 to 500,000 USP units daily. Hypoparathyroidism: 50,000 to 200,000 USP units daily concomitantly with calcium lactate 4 g, six times per day. DOSAGE MUST BE INDIVIDUALIZED UNDER CLOSE MEDICAL SUPERVISION. Calcium intake should be adequate. Blood calcium and phosphorus determinations must be made every 2 weeks or more frequently if necessary. X-rays of the bones should be taken ev...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50728,31258,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50729,25795,'N/A',0.0,NULL,24,7,'علاج الروماتيزم -- تقليل الالام المفاصل و العظام -- تقليل الالتهابات للمفاصل و العظام -- الحفاظ علي السائل الغضروفي','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50730,11763,'N/A',50.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 50 mg (عن طريق الحقن). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50731,21429,'6f41228b-974a-443b-a313-2fbb3d845915',250.0,400.0,12,7,'Standard Dose: 250.0mg. DOSAGE AND ADMINISTRATION Adults Ciprofloxacin tablets should be administered orally to adults as described in the Dosage Guidelines table. The determination of dosage for any particular patient must take into consideration the severity and nature of the infection, the susceptibility of the causative organism, the integrity of the patient''s host-defense mechanisms, and the status of renal function and hepatic function. The duration of treatment depends upon the severity of infection. The usual d...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50732,14343,'N/A',0.15,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.15 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50733,22534,'N/A',3.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50734,21142,'N/A',2.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50735,30832,'N/A',0.4,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.4 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50736,21721,'b73bf908-7979-4955-af20-0414388920da',2.5,NULL,24,7,'Standard Dose: 2.5mg. 2 DOSAGE AND ADMINISTRATION Enter section text here Letrozole tablets are taken orally without regard to meals (2): Recommended dose: 2.5 mg once daily (2.1) Patients with cirrhosis or severe hepatic impairment: 2.5 mg every other day (2.5, 5.3) 2.1 Recommended Dose The recommended dose of letrozole tablets is one 2.5 mg tablet administered once a day, without regard to meals. 2.2 Use in Adjuvant Treatment of Early Breast Cancer In the adjuvant setting, the optimal duration of treatment with let...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50737,19018,'75f0cde5-c419-416d-9c13-bfc03bd83b1d',5.0,NULL,24,7,'Standard Dose: 5.0mg. DOSAGE AND ADMINISTRATION: DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND RESPONSE OF THE PATIENT. A single oral dose of diphenhydramine hydrochloride is quickly absorbed with maximum activity occurring in approximately one hour. The duration of activity following an average dose of diphenhydramine hydrochloride is from four to six hours. ADULTS: 25 to 50 mg three or four times daily. The nighttime sleep-aid dosage is 50 mg at bedtime. CHILDREN: (over 20 lb): 12.5 to 25 mg three to f...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50738,5709,'N/A',7.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 7 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50739,20497,'N/A',0.0,NULL,24,7,'لانقاص الوزن','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50740,28346,'N/A',0.3,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.3 g (عن طريق المهبل). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50741,22967,'N/A',30.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 30 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50742,5496,'N/A',0.0,NULL,24,7,'علاج التهابات المفاصل ولعلاج العديد من الآلام منها الآلام المصاحبة للدورة الشهرية، كما يستخدم أيضا لإنقاص الوزن ولعلاج الغثيان والقيء خاصة الغثيان الصباحي أثناء الحمل .','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50743,27131,'a26d709b-b294-4b02-9a88-7e840f099a33',50.0,NULL,NULL,7,'Standard Dose: 50.0mg. DOSAGE AND ADMINISTRATION Sodium Bicarbonate Injection, USP is administered by the intravenous route. In cardiac arrest, a rapid intravenous dose of one to two 50 mL vials (44.6 to 100 mEq) may be given initially and continued at a rate of 50 mL (44.6 to 50 mEq) every 5 to 10 minutes if necessary (as indicated by arterial pH and blood gas monitoring) to reverse the acidosis. Caution should be observed in emergencies where very rapid infusion of large quantities of bicarbonate is indicated. Bicar...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50744,22585,'d82243b9-3e56-4a2b-8750-cb95ec106885',5.0,NULL,24,7,'Standard Dose: 5.0mg. DOSAGE AND ADMINISTRATION The dose of BISOPROLOL FUMARATE must be individualized to the needs of the patient. The usual starting dose is 5 mg once daily. In some patients, 2.5 mg may be an appropriate starting dose (see Bronchospastic Disease in WARNINGS). If the antihypertensive effect of 5 mg is inadequate, the dose may be increased to 10 mg and then, if necessary, to 20 mg once daily. Patients with Renal or Hepatic Impairment In patients with hepatic impairment (hepatitis or cirrhosis) or ren...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50745,21005,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50746,13174,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50747,9374,'N/A',0.0,NULL,24,7,'مضمضة للفم.','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50748,3869,'c83616c9-c222-4e3e-91bd-c7839406bb2a',30.0,NULL,24,7,'Standard Dose: 30.0mg. 2 DOSAGE AND ADMINISTRATION 2.1 Recommended DoseKAPIDEX is available as capsules in 30 mg and 60 mg strengths for adult use. Directions for use in each indication are summarized in Table 1. Table 1: KAPIDEX Dosing Recommendations Indication Recommended Dose Frequency Healing of EE 60 mg Once daily for up to 8 weeks Maintenance of Healed EE 30 mg Once daily* Symptomatic Non-Erosive GERD 30 mg Once daily for 4 weeks * Controlled studies did not extend beyond 6 months. 2.2 Special Populations No ad...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50749,24376,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50750,20651,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50751,28610,'N/A',0.125,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.125 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50752,32585,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50753,16296,'N/A',4.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 4 g (عن طريق الحقن). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50754,1899,'N/A',0.4,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.4 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50755,31703,'a732b303-9bbd-42ba-a7c5-61c21629ba93',1250.0,NULL,24,7,'Standard Dose: 1250.0mg. DOSAGE AND ADMINISTRATION The recommended dose of XELODA is 1250 mg/m2 administered orally twice daily (morning and evening; equivalent to 2500 mg/m2 total daily dose) for 2 weeks followed by a 1-week rest period given as 3-week cycles. XELODA tablets should be swallowed with water within 30 minutes after a meal. In combination with docetaxel, the recommended dose of XELODA is 1250 mg/m2 twice daily for 2 weeks followed by a 1-week rest period, combined with docetaxel at 75 mg/m2 as a 1-hour int...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50756,23530,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50757,18331,'N/A',3.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50758,23097,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50759,26610,'217e52b5-3a7b-4bbe-af3c-b18de7d426c3',15.0,NULL,24,7,'Standard Dose: 15.0mg. 2 DOSAGE AND ADMINISTRATION InitialDose RecommendedDose MaximumDose Schizophrenia – adults (2.1) 10-15 mg/day 10-15 mg/day 30 mg/day Schizophrenia – adolescents (2.1) 2 mg/day 10 mg/day 30 mg/day Bipolar mania – adults: monotherapy or as an adjunct to lithium or valproate (2.2) 15 mg/day 15 mg/day 30 mg/day Bipolar mania – pediatric patients: monotherapy or as an adjunct to lithium or valproate (2.2) 2 mg/day 10 mg/day 30 mg/day As an adjunct to antidepressants for the treatment of major depress...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50760,13891,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50761,1056,'94a59260-d2b6-464a-b5b9-bbc599e57e10',16.0,NULL,24,7,'Standard Dose: 16.0mg. 2 DOSAGE AND ADMINISTRATION Starting Dose Target Dose Adult Hypertension (2.1) 16 mg tablet once daily 8 – 32 mg tablet total daily dose Pediatric Hypertension (1 to < 6 years) (2.2) 0.20 mg/kg oral suspension once daily 0.05 – 0.4 mg/kg oral suspension once daily or consider divided dose Pediatric Hypertension (6 to < 17 years) (2.2) < 50 kg 4 – 8 mg tablet once daily >50 kg 8 – 16 mg tablet once daily < 50 kg 4 – 16 mg tablet once daily or consider divided dose > 50 kg 4 – 32 mg tablet once da...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50762,6292,'N/A',3.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50763,15365,'N/A',20.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 20 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50764,20706,'218fba79-c773-482d-90aa-7cf678694c36',0.0,NULL,24,7,'2 DOSAGE AND ADMINISTRATION Patients 1 year of age or older: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times on Day 1. Instill one drop two to four times daily in the affected eye(s) while awake on Days 2 through 7. Patients 1 year of age or older: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times on Day 1. Instill one drop two to four times daily in the affected eye(s) while awake on Days 2 through 7. (2)','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50765,7980,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50766,16845,'7b38ac8a-4540-4eb2-aedd-9aa966d22190',100.0,NULL,24,7,'Standard Dose: 100.0mg. DOSAGE AND ADMINISTRATION Therapy should be individualized according to patient response. Use the smallest dosage necessary to achieve the required response. Adults For EdemaThe usual adult dosage is 25 to 100 mg daily as a single or divided dose. Many patients with edema respond to intermittent therapy, i.e., administration on alternate days or on three to five days each week. With an intermittent schedule, excessive response and the resulting undesirable electrolyte imbalance are less likely t...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50767,32938,'N/A',2.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50768,4710,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50769,22836,'837e004e-efd4-4dab-b6ff-932bf0e63de4',0.75,NULL,NULL,7,'Standard Dose: 0.75mg. 2 DOSAGE AND ADMINISTRATION The first tablet is taken orally as soon as possible within 72 hours after unprotected intercourse. The second tablet should be taken 12 hours after the first dose. Efficacy is better if levonorgestrel tablet, 0.75 mg is taken as soon as possible after unprotected intercourse. (2) Take one tablet of levonorgestrel tablet, 0.75 mg orally as soon as possible within 72 hours after unprotected intercourse or a known or suspected contraceptive failure. Efficacy is better i...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50770,25854,'3827e1be-f328-45f7-b113-311b57039f8c',100.0,NULL,NULL,7,'Standard Dose: 100.0mg. 2 DOSAGE AND ADMINISTRATION RENFLEXIS is administered by intravenous infusion over a period of not less than 2 hours. (2.11) Crohn''s Disease: •5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks. Some adult patients who initially respond to treatment may benefit from increasing the dose to 10 mg/kg if they later lose their response. (2.1) Pediatric Crohn''s Disease: •5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks. (2.2) Ulcerative Colitis: •5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks. (2.3) Pedi...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50771,15944,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50772,20599,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50773,19800,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50774,26098,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50775,27586,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50776,17614,'a697e731-8d19-4845-8f31-16c4b19bb338',50.0,NULL,NULL,7,'Standard Dose: 50.0mg. DOSAGE AND ADMINISTRATION Carefully consider the potential benefits and risks of diclofenac potassium immediate-release tablets and other treatment options before deciding to use diclofenac potassium immediate-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). After observing the response to initial therapy with diclofenac potassium immediate-release tablets, the dose and frequency should be adjusted to suit...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50777,26500,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50778,2734,'N/A',0.0,NULL,24,7,'صابونة لتنظيف الوجة -- تقليل الاحمرار و الحكة -- علاج حب الشباب','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50779,20260,'N/A',0.4,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.4 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50780,25892,'cb995e92-295e-4638-a064-978211f5afe1',0.5,NULL,24,7,'Standard Dose: 0.5mg. 2 DOSAGE AND ADMINISTRATION The recommended starting dose is 0.5 mg orally before each meal if HbA1c is less than 8%; and 1 or 2 mg orally before each meal if HbA1c is 8% or greater. ( 2.1) The recommended dose range is 0.5 mg to 4 mg before meals, with a maximum daily dose of 16 mg. ( 2.1) The patient’s dose should be doubled up to 4 mg with each meal until satisfactory glycemic control is achieved. At least one week should elapse to assess response after each dose adjustment. ( 2.1) Instruct p...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50781,27090,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50782,21496,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50783,6752,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50784,21619,'de8990a6-f3b6-478f-acbe-eda961b6da4b',500.0,NULL,24,7,'Standard Dose: 500.0mg. DOSAGE AND ADMINISTRATION Amoxicillin capsules may be given without regard to meals. However, food effect studies have not been performed with the 500 mg formulation. Neonates and infants aged ≤ 12 weeks (≤ 3 months): Due to incompletely developed renal function affecting elimination of amoxicillin in this age group, the recommended upper dose of amoxicillin is 30 mg/kg/day divided q12h.Adults and pediatric patients >3 months: * Dosing for infections caused by less susceptible organisms should f...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50785,12410,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50786,13574,'N/A',0.0,NULL,24,7,'علاج تقرحات الفم -- ووقف الشعور بالالم','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50787,14296,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50788,21436,'9bc31f67-cfce-4ad6-9c07-3845ead3542c',300.0,NULL,24,7,'Standard Dose: 300.0mg. DOSAGE AND ADMINISTRATION Carefully consider the potential benefits and risks of a ketoprofen immediate-release capsules and ketoprofen extended-release capsules and other treatment options before deciding to use ketoprofen immediate-release capsules and ketoprofen extended-release capsules. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). After observing the response to initial therapy with ketoprofen immediate-release ca...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50789,13328,'2324d60b-4f49-4759-a46e-a06bfce7e8aa',7.0,NULL,8,7,'Standard Dose: 7.0mg. 2 DOSAGE AND ADMINISTRATION Pre-Treatment Assessment Following Acute Ingestion (2.1): Obtain a plasma or serum sample to assay for acetaminophen concentration at least 4 hours after ingestion. If the time of acetaminophen ingestion is unknown: Administer a loading dose of acetylcysteine injection immediately. Obtain an acetaminophen concentration to determine need for continued treatment. If the acetaminophen concentration cannot be obtained (or is unavailable or uninterpretable) within the 8-ho...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50790,25338,'2c8ffbd2-6b7a-42c7-b29e-e4de69dad9e6',90.0,NULL,24,7,'Standard Dose: 90.0mg. DOSAGE AND ADMINISTRATION Assisted Reproductive Technology Crinone® 8% is administered vaginally at a dose of 90 mg once daily in women who require progesterone supplementation. Crinone® 8% is administered vaginally at a dose of 90 mg twice daily in women with partial or complete ovarian failure who require progesterone replacement. If pregnancy occurs, treatment may be continued until placental autonomy is achieved, up to 10-12 weeks. Secondary Amenorrhea Crinone® 4% is administered vaginally e...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50791,8360,'4ad994f7-0caf-40aa-8824-ff438f7fc366',2.5,NULL,24,7,'Standard Dose: 2.5mg. DOSAGE AND ADMINISTRATION Depending on the severity and duration of symptoms, total daily dosage for adult psychotic patients may range initially from 2.5 mg to 10 mg and should be divided and given at 6 to 8 hour intervals. The smallest amount that will produce the desired results must be carefully determined for each individual, since optimal dosage levels of this potent drug vary from patient to patient. In general, the oral dose has been found to be approximately 2 to 3 times the parenteral ...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50792,32337,'N/A',7.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 7 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50793,12961,'365cbabe-535b-4c34-852b-6cd63782e3e5',2.5,5.0,24,7,'Standard Dose: 2.5mg. DOSAGE AND ADMINISTRATION Cetirizine hydrochloride oral solution can be taken without regard to food consumption. Children 2 to 5 Years for Chronic Urticaria: The recommended initial dose of cetirizine hydrochloride oral solution in children aged 2 to 5 years is 2.5 mg (½ teaspoonful) once daily. The dosage in this age group can be increased to a maximum dose of 5 mg per day given as 1 teaspoonful (5 mg) once daily, or as ½ teaspoonful (2.5 mg) given every 12 hours. Children 6 months to <2 years...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50794,30710,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50795,17971,'8609ed02-0b30-4c82-bab1-4d51d92ec224',20.0,NULL,NULL,7,'Standard Dose: 20.0mg. 2 DOSAGE AND ADMINISTRATION Indication Adult Pediatric MDD (2.1) 20 mg/day in am (initial dose) 10 to 20 mg/day (initial dose) OCD (2.2) 20 mg/day in am (initial dose) 10 mg/day (initial dose) Bulimia Nervosa (2.3) 60 mg/day in am - Panic Disorder (2.4) 10 mg/day (initial dose) - Depressive Episodes Associated with Bipolar I Disorder (2.5) Oral in combination with olanzapine: 5 mg of oral olanzapine and 20 mg of fluoxetine once daily (initial dose) - Consider tapering the dose of fluoxetine for ...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50796,23476,'c13bc0b8-7900-4ef4-98ed-e1315a08d95d',200.0,NULL,24,7,'Standard Dose: 200.0mg. DOSAGE AND ADMINISTRATION (see table below)Monitoring of blood levels has increased the efficacy and safety of anticonvulsants (see PRECAUTIONS, Laboratory Tests). Dosage should be adjusted to the needs of the individual patient. A low initial daily dosage with a gradual increase is advised. As soon as adequate control is achieved, the dosage may be reduced very gradually to the minimum effective level. Medication should be taken with meals.Conversion of patients from oral carbamazepine tablets ...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50797,20371,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50798,18519,'ebddb745-81f9-4b25-8739-b2886032ed26',5.0,NULL,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION CIALIS for use as needed: Starting dose: 10 mg up to once daily. Increase to 20 mg or decrease to 5 mg based upon efficacy/tolerability. Improves erectile function compared to placebo up to 36 hours post dose (2.1). CIALIS for once daily use: 2.5 mg taken once daily, without regard to timing of sexual activity. May increase to 5 mg based upon efficacy and tolerability (2.1). CIALIS may be taken without regard to food (2.2). 2.1 Erectile Dysfunction CIALIS for Use as N...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50799,16483,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50800,28312,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50801,19747,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50802,27372,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50803,1029,'N/A',1.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 1 tablet (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50804,10875,'c1730a51-4383-4c61-a9a1-7e1326bd0abe',5.0,10.0,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION Adult recommended starting dose: 5 mg orally once daily with a maximum of 10 mg orally once daily. (2.1) Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg orally once daily. (2.1) Pediatric starting dose: 2.5 mg to 5 mg orally once daily. (2.2) 2.1 Adults The usual initial antihypertensive oral dose of NORLIQVA is 5 mg orally once daily, and the maximum dose is 10 mg orally once daily. Small, fragile, or elderly patie...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50805,17698,'N/A',20.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 20 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50806,8437,'c519e446-fa50-487d-a54d-fc3bfdd7d034',5.0,NULL,8,7,'Standard Dose: 5.0mg. DOSAGE AND ADMINISTRATION For most patients, the recommended dose of cyclobenzaprine HCl tablets USP is 5 mg three times a day. Based on individual patient response, the dose may be increased to 10 mg three times a day. Use of cyclobenzaprine HCl tablets USP for periods longer than two or three weeks is not recommended. (see INDICATIONS AND USAGE). Less frequent dosing should be considered for hepatically impaired or elderly patients (see PRECAUTIONS, Impaired Hepatic Function, and Use in the El...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50807,24186,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50808,14749,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50809,33684,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50810,6113,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50811,30938,'N/A',0.0,NULL,24,7,'غسول لتفتيح وترطيب البشرة ومنع التصبغات وازالة الكلف','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50812,4273,'N/A',0.2,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50813,24790,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50814,25390,'N/A',0.0,NULL,24,7,'دعم البروستاتا -- تقليل الالاتهابات التناسلية -- تقليل الالام التناسلية والبولية -- تقليل الالتهابات التناسلية','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50815,25995,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50816,30339,'N/A',9.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 9 MU (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50817,25216,'dfe327e8-f6ab-41e5-bdef-d520118cd83a',5.0,NULL,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION •The recommended dosage of TRADJENTA is 5 mg orally once daily (2.1) •TRADJENTA can be taken with or without food (2.1) 2.1 Recommended Dosage and Administration The recommended dosage of TRADJENTA is 5 mg taken orally once daily, with or without food....','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50818,20933,'N/A',1.5,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 1.5 mg (Inhal.aerosol). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50819,17947,'b43f6b44-9de3-4efb-a467-487aee28f6a0',20.0,NULL,24,7,'Standard Dose: 20.0mg. 2 DOSAGE AND ADMINISTRATION Omeprazole delayed-release capsules should be taken before eating. In the clinical trials, antacids were used concomitantly with omeprazole delayed-release capsules. Patients should be informed that the omeprazole delayed-release capsule should be swallowed whole. For patients unable to swallow an intact capsule, alternative administration options are available [ See Dosage and Administration (2.8)]. Indication Omeprazole Dose Frequency Short-Term Treatment of Active ...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50820,2886,'4e936802-5b5d-4772-8b1d-4f30867ffa59',0.6,1.2,24,7,'Standard Dose: 0.6mg. 2 DOSAGE AND ADMINISTRATION The long term use of colchicine is established for FMF and the prophylaxis of gout flares but the safety and efficacy of repeat treatment for gout flares has not been evaluated. The dosing regimens for COLCRYS are different for each indication and must be individualized. The recommended dosage of COLCRYS depends on the patient''s age, renal function, hepatic function, and use of co-administered drugs [see Dose Modification for Co-administration of Interacting Drugs (2....','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50821,13256,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50822,9256,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50823,4996,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50824,1258,'N/A',1.5,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 1.5 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50825,14802,'c899b329-cc5e-4443-8e94-451314de47c9',0.0,NULL,24,7,'2 DOSAGE AND ADMINISTRATION Apply a pea-sized amount once daily to each of the five areas of the face: central forehead, chin, nose, each cheek. Brimonidine topical gel should be applied smoothly and evenly as a thin layer across the entire face avoiding the eyes and lips. Wash hands after applying brimonidine topical gel. Brimonidine topical gel is for topical use only and not for oral, ophthalmic, or intravaginal use. •Apply a pea-sized amount once daily to each of the five areas of the face (','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50826,22805,'N/A',3.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3.6 mg (عن طريق الحقن). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50827,31721,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50828,29379,'d6718f02-8eea-4c2f-9aa2-65121d9a6e4c',8.0,NULL,24,7,'Standard Dose: 8.0mg. 2 DOSAGE AND ADMINISTRATION · Adults: 400 mg daily ( 2.1) 2.1 Adults The recommended dose of cefixime is 400 mg daily. This may be given as a 400 mg capsule daily. For the treatment of uncomplicated cervical/urethral gonococcal infections, a single oral dose of 400 mg is recommended. The capsule may be administered without regard to food. In the treatment of infections due to Streptococcus pyogenes, a therapeutic dosage of cefixime should be administered for at least 10 days. 2.2 Pediatric Patie...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50829,12315,'N/A',30.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 30 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50830,16108,'N/A',2.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50831,14426,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50832,936,'2B1B7B5F-2F20-418C-B1AC-794C2EF1CE5E',5.0,NULL,24,7,'Standard Dose: 5.0mg. DOSAGE AND ADMINISTRATION The dosages of ARICEPT® shown to be effective in controlled clinical trials are 5 mg and 10 mg administered once per day.The higher dose of 10 mg did not provide a statistically significantly greater clinical benefit than 5 mg. There is a suggestion, however, based upon order of group mean scores and dose trend analyses of data from these clinical trials, that a daily dose of 10 mg of ARICEPT® might provide additional benefit for some patients. Accordingly, whether or n...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50833,18107,'525136c9-7758-437b-b57b-94b905786825',30.0,NULL,NULL,7,'Standard Dose: 30.0mg. DOSAGE AND ADMINISTRATION Sodium citrate and citric acid oral solution should be taken diluted in water, followed by additional water, if desired. SHAKE WELL BEFORE USING. For Systemic Alkalization Usual Adult Dose 2 to 6 teaspoonfuls (10 to 30 mL), diluted in 1 to 3 ounces of water, after meals and at bedtime, or as directed by a physician. Usual Pediatric Dose 1 to 3 teaspoonfuls (5 to 15 mL), diluted in 1 to 3 ounces of water, after meals and at bedtime, or as directed by a physician. For chi...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50834,18831,'N/A',0.5,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.5 g (عن طريق المهبل). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50835,30509,'ea79f802-e9ac-480b-91e6-1e3900b11803',20.0,NULL,24,7,'Standard Dose: 20.0mg. 2 DOSAGE AND ADMINISTRATION NEXIUM is supplied as delayed-release capsules for oral administration or in packets for preparation of delayed-release oral suspensions. The recommended dosages are outlined in the table below. NEXIUM should be taken at least one hour before meals. The duration of proton pump inhibitor administration should be based on available safety and efficacy data specific to the defined indication and dosing frequency, as described in the Prescribing Information, and individua...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50836,22847,'N/A',0.0,NULL,24,7,'لوشن للشعر يقويه ويعيد حيويته. يساعد في تساقط الشعر والصلع لدى الرجال والنساء. مناسب لجميع أنواع الشعر','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50837,22639,'b3136363-6fcb-486d-b752-d53a1f8e2d69',500.0,NULL,NULL,7,'Standard Dose: 500.0mg. DOSAGE & ADMINISTRATION Methocarbamol Tablets USP 500 mg – Adults: Initial dosage: 3 tablets q.i.d. Maintenance dosage: 2 tablets q.i.d. Methocarbamol Tablets USP 750 mg – Adults: Initial dosage: 2 tablets q.i.d. Maintenance dosage: 1 tablet q.4h. or 2 tablets t.i.d. Six grams a day are recommended for the first 48 to 72 hours of treatment. (For severe conditions 8 grams a day may be administered). Thereafter, the dosage can usually be reduced to approximately 4 grams a day....','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50838,3583,'N/A',60.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 60 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50839,5081,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50840,18533,'3e823928-c853-4617-acad-21b27174aa7b',250.0,NULL,24,7,'Standard Dose: 250.0mg. DOSAGE AND ADMINISTRATION Optimal blood levels are obtained when Erythromycin Base Filmtab tablets are given in the fasting state (at least ½ hour and preferably 2 hours before meals). AdultsThe usual dosage of Erythromycin Base Filmtab is one 250 mg tablet four times daily in equally spaced doses or one 500 mg tablet every 12 hours. Dosage may be increased up to 4 g per day according to the severity of the infection. However, twice-a-day dosing is not recommended when doses larger than 1 g dail...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50841,17870,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50842,7256,'55b99f22-9eb2-4df6-9979-bc4c3af5e454',70.0,NULL,24,7,'Standard Dose: 70.0mg. DOSAGE AND ADMINISTRATION Whether given with carbidopa-levodopa or with levodopa, the optimal daily dose of carbidopa must be determined by careful titration. Most patients respond to a 1:10 proportion of carbidopa-levodopa, provided the daily dosage of carbidopa is 70 mg or more a day. The maximum daily dosage of carbidopa should not exceed 200 mg, since clinical experience with larger dosages is limited. If the patient is taking carbidopa-levodopa, the amount of carbidopa in carbidopa-levodopa...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50843,12879,'N/A',0.0,NULL,24,7,'كريم للترطيب و التلطيف للجلد -- يساعد علي الحماية من الجفاف','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50844,32139,'0522051a-d044-4cee-acbc-378a607b4855',100.0,NULL,6,7,'Standard Dose: 100.0mg. 2 DOSAGE AND ADMINISTRATION Contains 100 mg of calcium gluconate per mL which contains 9.3 mg (0.465 mEq) of elemental calcium (2.1) Administer intravenously (bolus or continuous infusion) via a secure intravenous line (2.1) See Full Prescribing Information (FPI) for dilution instructions, administration rates, and appropriate monitoring (2.1) Individualize the dose within the recommended range in adults and pediatric patients depending on the severity of symptoms of hypocalcemia, the serum calc...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50845,22003,'173018F5-FD76-4480-90F8-4B7EFE328444',40.0,NULL,24,7,'Standard Dose: 40.0mg. DOSAGE AND ADMINISTRATION Maxaquin (lomefloxacin HCl) may be taken without regard to meals. Sucralfate and antacids containing magnesium or aluminum, or Videx® (didanosine), chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 4 hours before or 2 hours after taking lomefloxacin. Risk of reaction to solar UVA light may be reduced by taking Maxaquin at least 12 hours before exposure to the sun (eg, in the evening). (See Clinical Pharmacology.)See Indicatio...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50846,962,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50847,2400,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50848,6777,'2e1f1640-c6ff-456f-8bec-ec3251065f46',50.0,NULL,24,7,'Standard Dose: 50.0mg. DOSAGE AND ADMINISTRATION Adult Hypertensive Patients: Losartan potassium tablets may be administered with other antihypertensive agents, and with or without food. Dosing must be individualized. The usual starting dose of losartan potassium tablets is 50 mg once daily, with 25 mg used in patients with possible depletion of intravascular volume (e.g., patients treated with diuretics) (see WARNINGS, Hypotension — Volume-Depleted Patients) and patients with a history of hepatic impairment (see PREC...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50849,7438,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50850,10272,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50851,12627,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50852,29518,'f15b043d-fcfa-4ade-a3da-76700c0c5c2a',0.004,NULL,24,7,'Standard Dose: 0.004mg. DOSAGE AND ADMINISTRATION Prograf injection (tacrolimus injection) For IV Infusion Only NOTE: Anaphylactic reactions have occurred with injectables containing castor oil derivatives. See WARNINGS. In patients unable to take oral Prograf capsules, therapy may be initiated with Prograf injection. The initial dose of Prograf should be administered no sooner than 6 hours after transplantation. The recommended starting dose of Prograf injection is 0.01 mg/kg/day (heart) or 0.03-0.05 mg/kg/day (liver,...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50853,13009,'325a5d0e-9a72-4015-9fcd-1655fb504cee',20.0,NULL,24,7,'Standard Dose: 20.0mg. 2 DOSAGE AND ADMINISTRATION Take orally with or without food, at any time of day. (2.1) Assess LDL-C when clinically appropriate, as early as 4 weeks after initiating CRESTOR, and adjust dosage if necessary. (2.1) Adults: Recommended dosage range is 5 to 40 mg once daily. (2.1) Pediatric Patients with HeFH: Recommended dosage range is 5 to 10 mg once daily for patients aged 8 to less than 10 years of age, and 5 to 20 mg once daily for patients aged 10 years and older. (2.2) Pediatric Patients wi...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50854,23049,'N/A',0.0,NULL,24,7,'فيتامينات متعددة وحديد --لعلاج الانيميا والضعف العام في الاطفال','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50855,26953,'N/A',30.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 30 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50856,18068,'aa294be5-9015-4f6a-8a92-a71a2b22d1b2',0.0,NULL,NULL,7,'DOSAGE AND ADMINISTRATION Adults and children Thoroughly massage permethrin cream, 5% into the skin from the head to the soles of the feet. Scabies rarely infests the scalp of adults, although the hairline, neck, temple, and forehead may be infested in infants and geriatric patients. Usually 30 grams is sufficient for an average adult. The cream should be removed by washing (shower or bath) after 8 to 14 hours. Infants should be treated on the scalp, temple, and forehead. ONE APPLICATION IS GENE','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50857,26547,'a3d17e8d-a8ce-4e1a-9ec2-13736af1d7b5',60.0,NULL,24,7,'Standard Dose: 60.0mg. DOSAGE AND ADMINISTRATION Seasonal Allergic Rhinitis Adults and Children 12 Years and OlderThe recommended dose of Fexofenadine Hydrochloride Tablets is 60 mg twice daily, or 180 mg once daily with water. A dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function (see CLINICAL PHARMACOLOGY). Children 6 to 11 YearsThe recommended dose of Fexofenadine Hydrochloride Tablets is 30 mg twice daily with water. A dose of 30 mg once daily is recommended as th...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50858,2027,'a7b85288-9099-4c20-beb7-ee2be484c9b9',25.0,NULL,24,7,'Standard Dose: 25.0mg. DOSAGE AND ADMINISTRATION Captopril should be taken one hour before meals. Dosage must be individualized. Hypertension Initiation of therapy requires consideration of recent antihypertensive drug treatment, the extent of blood pressure elevation, salt restriction, and other clinical circumstances. If possible, discontinue the patient’s previous antihypertensive drug regimen for one week before starting captopril. The initial dose of captopril is 25 mg b.i.d. or t.i.d. If satisfactory reduction o...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50859,26264,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50860,21822,'a1e2c14f-0682-4b19-9159-de0aca1960c6',5.0,NULL,NULL,7,'Standard Dose: 5.0mg. DOSAGE AND ADMINISTRATION When Lidocaine Ointment 5% is used concomitantly with other products containing lidocaine, the total dose contributed by all formulations must be kept in mind. Adult A single application should not exceed 5 g of Lidocaine Ointment 5%, containing 250 mg of lidocaine base (equivalent chemically to approximately 300 mg of lidocaine hydrochloride). This is roughly equivalent to squeezing a six (6) inch length of ointment from the tube. In a 70 kg adult this dose equals 3.6 ...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50861,24347,'N/A',5.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 5 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50862,4364,'9ef08e09-1098-35cc-e053-2a95a90a3e1d',75.0,NULL,NULL,7,'Standard Dose: 75.0mg. 2 DOSAGE AND ADMINISTRATION •Recommended dosage for acute treatment of migraine: 75 mg taken orally, as needed. (2.1) •The safety of using more than 18 doses in a 30-day period has not been established. (2.1) •Recommended dosage for preventive treatment of episodic migraine: 75 mg taken orally every other day. (2.2) •The maximum dose in a 24-hour period is 75 mg. (2.1) 2.1 Recommended Dosing for Acute Treatment of Migraine The recommended dose of NURTEC ODT is 75 mg taken orally, as needed. The ...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50863,14137,'1310e776-65c8-413d-aab5-81a8c15719c5',50.0,300.0,24,7,'Standard Dose: 50.0mg. 2 DOSAGE AND ADMINISTRATION VIMPAT may be taken with or without food. When using VIMPAT oral solution, it is recommended that a calibrated measuring device be obtained and used. A household teaspoon or tablespoon is not an adequate measuring device. Healthcare providers should recommend a device that can measure and deliver the prescribed dose accurately, and provide instructions for measuring the dosage. Partial-onset seizures (2.1): Initially, give 50 mg twice daily (100 mg/day). The dose may ...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50864,32448,'N/A',10.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 10 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50865,33377,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50866,30571,'ea79f802-e9ac-480b-91e6-1e3900b11803',20.0,NULL,24,7,'Standard Dose: 20.0mg. 2 DOSAGE AND ADMINISTRATION NEXIUM is supplied as delayed-release capsules for oral administration or in packets for preparation of delayed-release oral suspensions. The recommended dosages are outlined in the table below. NEXIUM should be taken at least one hour before meals. The duration of proton pump inhibitor administration should be based on available safety and efficacy data specific to the defined indication and dosing frequency, as described in the Prescribing Information, and individua...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50867,619,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50868,2405,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50869,28017,'A5C67C7A-0FFD-4C51-BADB-B5109D4D25B6',50.0,NULL,24,7,'Standard Dose: 50.0mg. DOSAGE AND ADMINISTRATION Hypertension The initial dose of atenolol is 50 mg given as one tablet a day either alone or added to diuretic therapy. The full effect of this dose will usually be seen within one to two weeks. If an optimal response is not achieved, the dosage should be increased to atenolol 100 mg given as one tablet a day. Increasing the dosage beyond 100 mg a day is unlikely to produce any further benefit.Atenolol may be used alone or concomitantly with other antihypertensive agent...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50870,17129,'6541ab19-3cfc-4786-9cfe-0455f428edb5',60.0,NULL,24,7,'Standard Dose: 60.0mg. DOSAGE AND ADMINISTRATION THE CAPSULES SHOULD BE SWALLOWED WITHOUT CHEWING TO AVOID LOCAL IRRITATION OF THE MOUTH AND THROAT. Valproic Acid is administered orally. Valproic Acid is indicated as monotherapy and adjunctive therapy in complex partial seizures in adults and pediatric patients down to the age of 10 years, and in simple and complex absence seizures. As the Valproic Acid dosage is titrated upward, concentrations of phenobarbital, carbamazepine, and/or phenytoin may be affected (see PRE...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50871,22821,'aaaf3bea-1b21-4edf-9300-b7159ea9ede8',25.0,NULL,24,7,'Standard Dose: 25.0mg. 2 DOSAGE AND ADMINISTRATION •MYRBETRIQ and MYRBETRIQ Granules are two different products and they are not substitutable on a milligram-per-milligram basis. Select the recommended product (MYRBETRIQ or MYRBETRIQ Granules) based on the indication and patient’s weight. Do not combine MYRBETRIQ and MYRBETRIQ Granules to achieve the total dose. A recommended dosage for MYRBETRIQ Granules for adults has not been determined. (2.1) OAB in Adults •The recommended starting dose of MYRBETRIQ is 25 mg orall...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50872,18274,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50873,1793,'d82243b9-3e56-4a2b-8750-cb95ec106885',5.0,NULL,24,7,'Standard Dose: 5.0mg. DOSAGE AND ADMINISTRATION The dose of BISOPROLOL FUMARATE must be individualized to the needs of the patient. The usual starting dose is 5 mg once daily. In some patients, 2.5 mg may be an appropriate starting dose (see Bronchospastic Disease in WARNINGS). If the antihypertensive effect of 5 mg is inadequate, the dose may be increased to 10 mg and then, if necessary, to 20 mg once daily. Patients with Renal or Hepatic Impairment In patients with hepatic impairment (hepatitis or cirrhosis) or ren...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50874,5108,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50875,3534,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50876,24985,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50877,20310,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50878,25770,'N/A',1.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 1 TU (عن طريق الحقن). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50879,8649,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50880,12583,'70776952-a340-4405-9cf0-f0988ff8097b',14.0,NULL,24,7,'Standard Dose: 14.0mg. DOSAGE AND ADMINISTRATION Magnesium Sulfate in Water for Injection is intended for intravenous use only. For the management of pre-eclampsia or eclampsia, intravenous infusions of dilute solutions of magnesium (1% to 8%) are often given in combination with intramuscular injections of 50% Magnesium Sulfate Injection, USP. Therefore, in the clinical conditions cited below, both forms of therapy are noted, as appropriate. Continuous maternal administration of magnesium sulfate in pregnancy beyond 5...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50881,26137,'0a3b8e0e-efb0-465b-84cb-d120b3096ebd',1.0,NULL,NULL,7,'Standard Dose: 1.0mg. 2 DOSAGE AND ADMINISTRATION 2.1 Important Administration Instructions Administer Calcium Chloride Injection by slow intravenous infusion in a central or deep vein in adults and pediatric patients (with or without renal impairment); do not administer by bolus [see Warnings and Precautions (5.2, 5.4)]. The maximum recommended infusion rate is 1 mL/minute (100 mg/minute). Additional important administration instructions regarding Calcium Chloride Injection are as follows: • Do not use intramuscular...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50882,16591,'7b38ac8a-4540-4eb2-aedd-9aa966d22190',100.0,NULL,24,7,'Standard Dose: 100.0mg. DOSAGE AND ADMINISTRATION Therapy should be individualized according to patient response. Use the smallest dosage necessary to achieve the required response. Adults For EdemaThe usual adult dosage is 25 to 100 mg daily as a single or divided dose. Many patients with edema respond to intermittent therapy, i.e., administration on alternate days or on three to five days each week. With an intermittent schedule, excessive response and the resulting undesirable electrolyte imbalance are less likely t...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50883,5843,'N/A',7.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 7 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50884,4572,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50885,29498,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50886,17036,'0a905e25-42b6-4937-a689-f01a8f22e644',750.0,NULL,24,7,'Standard Dose: 750.0mg. DOSAGE AND ADMINISTRATION The recommended dosage is 2 capsules 3 times a day at 8 hour intervals for a total daily dose of 750 mg....','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50887,20555,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50888,527,'f260ff2a-76a0-4672-9516-91c344b67890',250.0,NULL,24,7,'Standard Dose: 250.0mg. DOSAGE AND ADMINISTRATION The patient''s pretreatment body weight should be obtained for calculation of correct dosage. Amikacin Sulfate Injection, USP may be given intramuscularly or intravenously. The status of renal function should be estimated by measurement of the serum creatinine concentration or calculation of the endogenous creatinine clearance rate. The blood urea nitrogen (BUN) is much less reliable for this purpose. Reassessment of renal function should be made periodically during ther...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50889,2690,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50890,8143,'EE2B4869-CD13-489B-B12F-1CE4FE081157',500.0,NULL,NULL,7,'Standard Dose: 500.0mg. DOSAGE AND ADMINISTRATION The recommended initial dose of Nascobal Nasal Spray is one spray (500 mcg) administered in ONE nostril once weekly. Nascobal Nasal Spray should be administered at least one hour before or one hour after ingestion of hot foods or liquids. Periodic monitoring of serum B12 levels should be obtained to establish adequacy of therapy.Before the first dose and administration, the pump must be primed. Remove the clear plastic cover and the plastic safety clip from the pump. To...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50891,25158,'8fb45a78-b2d8-45dd-b844-0de21d1fdde9',600.0,NULL,NULL,7,'Standard Dose: 600.0mg. 2 DOSAGE AND ADMINISTRATION LYRICA is given orally with or without food. When discontinuing LYRICA, taper gradually over a minimum of 1 week. DPN Pain (2.1): Administer in 3 divided doses per day Begin dosing at 150 mg/day May be increased to a maximum of 300 mg/day within 1 week. PHN (2.2): Administer in 2 or 3 divided doses per day Begin dosing at 150 mg/day May be increased to 300 mg/day within 1 week Maximum dose of 600 mg/day. Adjunctive Therapy for Adult Patients with Partial Onset Seizure...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50892,28371,'N/A',7.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 7 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50893,4170,'7efed863-919d-458e-99e1-ce0cec95537a',5.0,40.0,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION Hypertension Adult: recommended initial dose is 5 mg once daily. Maximum dose is 40 mg daily (2.1). Pediatrics: recommended starting dose is 0.08 mg/kg (up to 5 mg) once daily (2.1). Heart Failure: Initiate at 2.5 mg twice daily. Titrate up to 20 mg twice daily as tolerated (2.2). Asymptomatic Left Ventricular Dysfunction: Initiate at 2.5 mg twice daily. Titrate up to 10 mg twice daily (2.3). Enalapril maleate oral solution is a ready-to-use solution intended for oral...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50894,30813,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50895,22262,'2142460a-5afa-f3f3-e063-6394a90ab647',400.0,NULL,NULL,7,'Standard Dose: 400.0mg. 2 DOSAGE AND ADMINISTRATION For Oral Inhalation Only. (2.1) The BRONCHITOL Tolerance Test is administered to identify patients who are appropriate for inhaled mannitol use. (2.1) Treatment of cystic fibrosis: 400 mg of BRONCHITOL (10 capsules) twice a day by oral inhalation, in the morning and evening, with the later dose taken 2-3 hours before bedtime. (2.2) 2.1 Required Testing and Evaluation Prior to Prescribing BRONCHITOL (BRONCHITOL Tolerance Test) Prior to prescribing BRONCHITOL for treatm...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50896,32897,'N/A',7.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 7 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50897,9485,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50898,8242,'N/A',30.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 30 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50899,21173,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50900,27635,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50901,31506,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50902,15648,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50903,14165,'92018a65-38f6-45f7-91d4-a34921b81d0d',5.0,7.5,24,7,'Standard Dose: 5.0mg. 2. DOSAGE AND ADMINIST R ATION Adult and pediatric patients greater than 40 kg Starting dose is 2.5 (pediatrics and vulnerable adults) or 5 mg twice daily with food. After 2 weeks of treatment, adjust dose based on heart rate. The maximum dose is 7.5 mg twice daily. (2.1) Pediatric patients less than 40 kg Starting dose is 0.05 mg/kg twice daily with food. Adjust dose at two-week intervals by 0.05 mg/kg based on heart rate. Maximum dose is 0.2 mg/kg (patients 6 months to less than 1 year old) or...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50904,20752,'871E2A73-A1E9-4952-8CF2-15DA430117CE',2.0,NULL,24,7,'Standard Dose: 2.0mg. DOSAGE AND ADMINISTRATION (1 capsule = 2 mg)Patients should receive appropriate fluid and electrolyte replacement as needed. Acute Diarrhea Adults: The recommended initial dose is 4mg (two capsules) followed by 2 mg (one capsule) after each unformed stool. Daily dose should not exceed 16mg (eight capsules). Clinical improvement is usually observed within 48 hours. Children: In children 2 to 5 years of age (20 kg or less), the non-prescription liquid formulation (IMODIUM® A-D 1 mg/7.5 mL) should ...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50905,13642,'N/A',0.0,NULL,24,7,'سيلينيوم','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50906,15352,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50907,16861,'7b38ac8a-4540-4eb2-aedd-9aa966d22190',100.0,NULL,24,7,'Standard Dose: 100.0mg. DOSAGE AND ADMINISTRATION Therapy should be individualized according to patient response. Use the smallest dosage necessary to achieve the required response. Adults For EdemaThe usual adult dosage is 25 to 100 mg daily as a single or divided dose. Many patients with edema respond to intermittent therapy, i.e., administration on alternate days or on three to five days each week. With an intermittent schedule, excessive response and the resulting undesirable electrolyte imbalance are less likely t...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50908,19520,'4fe5abcd-4d9c-486c-9ac5-32c27845eae8',1000.0,NULL,24,7,'Standard Dose: 1000.0mg. DOSAGE AND ADMINISTRATION Levetiracetam is indicated as adjunctive treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy. Partial Onset Seizures Adults 16 Years And Older In clinical trials, daily doses of 1000 mg, 2000 mg, and 3000 mg, given as twice daily dosing, were shown to be effective. Although in some studies there was a tendency toward greater response with higher dose (see CLINICAL STUDIES ), a consistent increase in response with increased d...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50909,13236,'N/A',30.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 30 mg (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50910,155,'N/A',0.0,NULL,24,7,'مرطب وملطف للجلد -- يعمل علي تلطيف الجلد وحمايته من الجفاف','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50911,27622,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50912,14945,'N/A',20.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 20 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50913,28374,'N/A',0.0,NULL,24,7,'مكمل غذائي','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50914,8435,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50915,4320,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50916,19485,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50917,21863,'c1730a51-4383-4c61-a9a1-7e1326bd0abe',5.0,10.0,24,7,'Standard Dose: 5.0mg. 2 DOSAGE AND ADMINISTRATION Adult recommended starting dose: 5 mg orally once daily with a maximum of 10 mg orally once daily. (2.1) Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg orally once daily. (2.1) Pediatric starting dose: 2.5 mg to 5 mg orally once daily. (2.2) 2.1 Adults The usual initial antihypertensive oral dose of NORLIQVA is 5 mg orally once daily, and the maximum dose is 10 mg orally once daily. Small, fragile, or elderly patie...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50918,14072,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50919,13996,'N/A',2.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50920,33872,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50921,16321,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50922,19463,'N/A',0.3,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.3 g (عن طريق المهبل). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50923,23938,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50924,2544,'N/A',1.5,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 1.5 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50925,17388,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50926,21816,'a1e2c14f-0682-4b19-9159-de0aca1960c6',5.0,NULL,NULL,7,'Standard Dose: 5.0mg. DOSAGE AND ADMINISTRATION When Lidocaine Ointment 5% is used concomitantly with other products containing lidocaine, the total dose contributed by all formulations must be kept in mind. Adult A single application should not exceed 5 g of Lidocaine Ointment 5%, containing 250 mg of lidocaine base (equivalent chemically to approximately 300 mg of lidocaine hydrochloride). This is roughly equivalent to squeezing a six (6) inch length of ointment from the tube. In a 70 kg adult this dose equals 3.6 ...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50927,30708,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50928,9019,'N/A',0.125,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.125 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50929,33548,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50930,22625,'N/A',3.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50931,7082,'80aab848-8739-4259-a092-ed99d0f6a56d',250.0,NULL,24,7,'Standard Dose: 250.0mg. 2 DOSAGE AND ADMINISTRATION Prior to administering, evaluate patients for evidence of chronic or active liver disease. ( 2.1) Fingernail onychomycosis: One 250 mg tablet, once daily for 6 weeks. ( 2.2) Toenail onychomycosis: One 250 mg tablet, once daily for 12 weeks. ( 2.2) 2.1 Assessment Prior to Initiation Before administering terbinafine tablets, evaluate patients for evidence of chronic or active liver disease [see Contraindications (4) and Warnings and Precautions (5.1)]. 2.2 Dosage Finger...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50932,29397,'e122435e-cd0b-4c90-940a-b7a0d090d866',300.0,NULL,24,7,'Standard Dose: 300.0mg. 2 DOSAGE AND ADMINISTRATION Recommended dose for the treatment of HIV or chronic hepatitis B: 300 mg once daily taken orally without regard to food. (2.1) Dose recommended in renal impairment:Creatinine clearance 30–49 mL/min: 300 mg every 48 hours. (2.2)Creatinine clearance 10–29 mL/min: 300 mg every 72 to 96 hours. (2.2)Hemodialysis: 300 mg every 7 days or after approximately 12 hours of dialysis. (2.2) 2.1 Recommended Dose For the treatment of HIV-1 or chronic hepatitis B: The dose of VIREAD ...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50933,21734,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50934,8869,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50935,13385,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50936,8250,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50937,6320,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50938,26323,'N/A',0.0,NULL,24,7,'1- مرطب قوي للجلد لتجديد خلايا البشرة.','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50939,16987,'N/A',0.0,NULL,24,7,'مساج لآلام العظام والعضلات','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50940,20748,'5fa97bf5-28a2-48f1-8955-f56012d296be',25.0,NULL,24,7,'Standard Dose: 25.0mg. 2 DOSAGE AND ADMINISTRATION •MM combination therapy: 25 mg once daily orally on Days 1-21 of repeated 28-day cycles. (2.1). •MM maintenance therapy following auto-HSCT: 10 mg once daily continuously on Days 1-28 of repeated 28-day cycles (2.1). •MDS: 10 mg once daily (2.2). •MCL: 25 mg once daily orally on Days 1-21 of repeated 28-day cycles (2.3). •FL or MZL: 20 mg once daily orally on Days 1-21 of repeated 28-day cycles for up to 12 cycles (2.4). •Renal impairment: Adjust starting dose based o...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50941,25919,'68fba58a-7748-4581-8432-f5286c46d90a',4.0,NULL,24,7,'Standard Dose: 4.0mg. DOSAGE AND ADMINISTRATION Keflex is administered orally. Adults— The adult dosage ranges from 1 to 4 g daily in divided doses. The 333 mg and 750 mg strengths should be administered such that the daily dose is within 1 to 4 grams per day. The usual adult dose is 250 mg every 6 hours. For the following infections, a dosage of 500 mg may be administered every 12 hours: streptococcal pharyngitis, skin and skin structure infections, and uncomplicated cystitis in patients over 15 years of age. Cystit...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50942,22089,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50943,28932,'856ecdad-a8e0-4bda-a217-cd7948ddfa59',60.0,NULL,24,7,'Standard Dose: 60.0mg. 2 DOSAGE AND ADMINISTRATION Valproate Sodium Injection is intended for intravenous use only. Epilepsy Complex Partial Seizures in Adults and Children 10 years of age or older: Initial dose is 10 to 15 mg/kg/day, increasing at 1 week intervals by 5 to 10 mg/kg/day to achieve optimal clinical response. Maximum recommended dose is 60 mg/kg/day ( 2.1) Simple and Complex Absence Seizures: Initial dose is 10 to 15 mg/kg/day, increasing at 1 week intervals by 5 to 10 mg/kg/day to achieve optimal clinic...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50944,7075,'17a20462-d9d2-43ac-bcad-603e8cc76e3b',100.0,200.0,24,7,'Standard Dose: 100.0mg. 2 DOSAGE AND ADMINISTRATION Dosing is based on concomitant medications, indication, and patient age. (2.2, 2.4) To avoid an increased risk of rash, the recommended initial dose and subsequent dose escalations should not be exceeded. LAMICTAL Starter Kits and LAMICTAL ODT Patient Titration Kits are available for the first 5 weeks of treatment. (2.1, 16) Do not restart LAMICTAL in patients who discontinued due to rash unless the potential benefits clearly outweigh the risks. (2.1) Adjustments to m...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50945,30023,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50946,12973,'N/A',0.3,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.3 mg (عن طريق الأنف). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50947,22353,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50948,29637,'N/A',0.0,NULL,24,7,'يسرع عملية الحرق ويمد الجسم بالفيتامينات والمعادن','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50949,3680,'a26d709b-b294-4b02-9a88-7e840f099a33',50.0,NULL,NULL,7,'Standard Dose: 50.0mg. DOSAGE AND ADMINISTRATION Sodium Bicarbonate Injection, USP is administered by the intravenous route. In cardiac arrest, a rapid intravenous dose of one to two 50 mL vials (44.6 to 100 mEq) may be given initially and continued at a rate of 50 mL (44.6 to 50 mEq) every 5 to 10 minutes if necessary (as indicated by arterial pH and blood gas monitoring) to reverse the acidosis. Caution should be observed in emergencies where very rapid infusion of large quantities of bicarbonate is indicated. Bicar...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50950,4947,'N/A',3.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 3.6 mg (عن طريق الحقن). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50951,18218,'N/A',0.2,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50952,28394,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50953,13685,'a23a1cca-bc3e-48c5-abd9-82eddb52e91b',750.0,NULL,24,7,'Standard Dose: 750.0mg. 2 DOSAGE AND ADMINISTRATION Dosage in patients with normal renal function (2.1) Type of Infection Dose Every 24 hours Duration(days) Nosocomial Pneumonia (1.1) 750 mg 7–14 Community Acquired Pneumonia (1.2) 500 mg 7–14 Community Acquired Pneumonia (1.3) 750 mg 5 Acute Bacterial Sinusitis (1.4) 750 mg 5 500 mg 10–14 Acute Bacterial Exacerbation of Chronic Bronchitis (1.5) 500 mg 7 Complicated Skin and Skin Structure Infections (SSSI) (1.6) 750 mg 7–14 Uncomplicated SSSI (1.7) 500 mg 7–10 Chronic ...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50954,7106,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50955,14380,'N/A',0.4,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.4 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50956,26102,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50957,21524,'1310e776-65c8-413d-aab5-81a8c15719c5',50.0,300.0,24,7,'Standard Dose: 50.0mg. 2 DOSAGE AND ADMINISTRATION VIMPAT may be taken with or without food. When using VIMPAT oral solution, it is recommended that a calibrated measuring device be obtained and used. A household teaspoon or tablespoon is not an adequate measuring device. Healthcare providers should recommend a device that can measure and deliver the prescribed dose accurately, and provide instructions for measuring the dosage. Partial-onset seizures (2.1): Initially, give 50 mg twice daily (100 mg/day). The dose may ...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50958,4735,'f60a672d-8d6d-4d67-9a47-5547357e7b5b',20.0,NULL,24,7,'Standard Dose: 20.0mg. 2 DOSAGE AND ADMINISTRATION Dose range: 10 to 80 mg once daily (2.1). Recommended start dose: 10 or 20 mg once daily (2.1). Patients requiring large LDL-C reduction (>45%) may start at 40 mg once daily (2.1). Pediatric starting dose: 10 mg once daily; maximum recommended dose: 20 mg once daily (2.2). 2.1 Hyperlipidemia (Heterozygous Familial and Nonfamilial) and Mixed Dyslipidemia (Fredrickson Types IIa and IIb) The recommended starting dose of LIPITOR is 10 or 20 mg once daily. Patients who req...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50959,12820,'56a07381-7c51-4607-8131-f925a20d9074',10.0,40.0,24,7,'Standard Dose: 10.0mg. DOSAGE AND ADMINISTRATION Hypertension Initial Therapy: In patients with uncomplicated essential hypertension not on diuretic therapy, the recommended initial dose is 10 mg once a day. Dosage should be adjusted according to blood pressure response. The usual dosage range is 20 to 40 mg per day administered in a single daily dose. The antihypertensive effect may diminish toward the end of the dosing interval regardless of the administered dose, but most commonly with a dose of 10 mg daily. This c...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50960,30656,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50961,32388,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50962,8554,'e90f98d9-3c9b-4e75-ba18-5517283eadf0',5.0,NULL,12,7,'Standard Dose: 5.0mg. 2 DOSAGE & ADMINISTRATION ALINIA Tablets should not be administered to pediatric patient 11 years of age or younger ( 2.1) Dosage for treatment of diarrhea caused by G. lambliaor C. parvum( 2.1): Age Dosage Duration 1-3 years 5 mL of ALINIA for Oral Suspension (100 mg nitazoxanide) every 12 hours with food 4-11 years 10 mL of ALINIA for Oral Suspension (200 mg nitazoxanide) every 12 hours with food 3 days 12 years and older One ALINIA Tablet (500 mg nitazoxanide) every 12 hours with food or25 mL...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50963,23020,'N/A',10.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 10 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50964,2597,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (50965,28888,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50966,20179,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50967,33406,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50968,15730,'N/A',2.0,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 2 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50969,20742,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50970,20453,'de8990a6-f3b6-478f-acbe-eda961b6da4b',500.0,NULL,24,7,'Standard Dose: 500.0mg. DOSAGE AND ADMINISTRATION Amoxicillin capsules may be given without regard to meals. However, food effect studies have not been performed with the 500 mg formulation. Neonates and infants aged ≤ 12 weeks (≤ 3 months): Due to incompletely developed renal function affecting elimination of amoxicillin in this age group, the recommended upper dose of amoxicillin is 30 mg/kg/day divided q12h.Adults and pediatric patients >3 months: * Dosing for infections caused by less susceptible organisms should f...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50971,16701,'N/A',0.2,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.2 g (عن طريق المهبل). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50972,8128,'dc2427ff-e566-4b48-b289-9e51c011250a',50.0,NULL,24,7,'Standard Dose: 50.0mg. 2 DOSAGE & ADMINISTRATION Application of one ORAVIG 50 mg buccal tablet to the gum region once daily for 14 consecutive days (2.1). Instruct patients not to crush, chew, or swallow tablets (2.2). 2.1 Basic Dosing Information The recommended dosing schedule for ORAVIG is the application of one 50 mg buccal tablet to the upper gum region (canine fossa) once daily for 14 consecutive days. 2.2 Administration Instructions ORAVIG should be applied in the morning, after brushing the teeth. The tablet s...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50973,18553,'ea79f802-e9ac-480b-91e6-1e3900b11803',20.0,NULL,24,7,'Standard Dose: 20.0mg. 2 DOSAGE AND ADMINISTRATION NEXIUM is supplied as delayed-release capsules for oral administration or in packets for preparation of delayed-release oral suspensions. The recommended dosages are outlined in the table below. NEXIUM should be taken at least one hour before meals. The duration of proton pump inhibitor administration should be based on available safety and efficacy data specific to the defined indication and dosing frequency, as described in the Prescribing Information, and individua...','General','DailyMed',1,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50974,32107,'N/A',0.0,NULL,24,7,'مكمل غذائى يستخدم فى دعم الجعاز العصبى','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50975,16301,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50976,22135,'2c8ffbd2-6b7a-42c7-b29e-e4de69dad9e6',90.0,NULL,24,7,'Standard Dose: 90.0mg. DOSAGE AND ADMINISTRATION Assisted Reproductive Technology Crinone® 8% is administered vaginally at a dose of 90 mg once daily in women who require progesterone supplementation. Crinone® 8% is administered vaginally at a dose of 90 mg twice daily in women with partial or complete ovarian failure who require progesterone replacement. If pregnancy occurs, treatment may be continued until placental autonomy is achieved, up to 10-12 weeks. Secondary Amenorrhea Crinone® 4% is administered vaginally e...','General','DailyMed',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50977,12864,'N/A',0.6,NULL,24,7,'الجرعة اليومية المحددة (WHO DDD): 0.6 g (عن طريق الفم). ملاحظة: هذه هي متوسط جرعة الصيانة للبالغين.','General','WHO ATC/DDD 2024',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(50978,14958,'N/A',0.0,NULL,24,7,'See package insert','General','Local_Scraper',0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(108972,30066,'6fda6b92-59ed-4180-af68-94052a5e82cf',5.0,1000.0,24,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Tablet',NULL,0,NULL,NULL,x'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',x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651f0482d482cc94c56f0cc2d48cc2cca4dcd2b01009ed90ad6',NULL,NULL),(108975,30066,'88d05db3-8bdc-47f1-bb00-6b4a71f98609',5.0,1000.0,24,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Tablet',NULL,0,NULL,NULL,x'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',x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651f0482d482cc94c56f0cc2d48cc2cca4dcd2b01009ed90ad6',NULL,NULL),(108978,30066,'6f5b628b-69da-4a04-a4d5-623b18d1fd5d',5.0,1000.0,24,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Tablet',NULL,0,NULL,NULL,x'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',x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651f0482d482cc94c56f0cc2d48cc2cca4dcd2b01009ed90ad6',NULL,NULL),(108987,30067,'6fda6b92-59ed-4180-af68-94052a5e82cf',5.0,1000.0,24,NULL,x'789ced58c16ee33610fd9539da80e3c6cea65beccd75dac4c06ed688b3288aa2075aa22c2212a99294bde9a9bfd1dfeb97f40d25d9b2e3c8498b165da0975d5a1c0e1f67de3c0e33a6ab8f8bc9f57734b9bda2c9d587d9ed6c717f37b99f7dbca50fd20be78557114518588c8c3eb3d2297cd59e0a6b785a625647d2bea3c952c1485aa325894886392f9699f48e4683f3f373ca5764acc8b247325842b150186e944fe14cc65a395e7ad932f31bd5d80da947e3e188facf0073523be5d55afe2bc0766615ae3170cd01446af8b432926aadf48a44c7ce2e35651693c89ca957c08656468bd8786b0ac5c1cea470ec2835366727bd6b7d77d327a1456656140146692d366548b671990ab84a454c4b95f1ee22c364942a1979930370573cf2d2795af2ef07a94938406200194e6b9c6c87c7605a93cc0bff480e8e45940ee9ca90369ea4f0941813d318c84bebe0313116bbe99846e113890408789b13711ad27dfa149edb200d662363daa406e042ae36ec628b21b2a54b392a512a373b6f9cad0b64eb8a8ff3c1c42a515160d03bfa1ec64593c4e071299ccc1440e526968c90525904e6a9bc10cae630a5de3455597c362f57294d33e11c7ddb1f20a57189587980ef648117d673084278bda1f16545c70382bd01e47d7ca9a158ae65668a0a94f1e6b38a14b21197963d7a8b3430c20122ce4ceb80516aaf32a6a1594b8b2defe47635e5e29143ae34ca0b6be0c88315d5f9e280bb9b52352be122560e94c5714b2c54c9ee30cd411cfeb7f2e03cbb0070fddf01630e5c315c841c82586d4998decda78132b665587137e90c816a8941cf6f0c5d56e3661edb244cdc3a41f5e7fedf5134d68d53e7b951abf4cc2af740d3c57ff36422cec10d87cd81e7883e72bdcdf2c2d8706d4c6aeb4ab669a6312c231ebbff15f48b5050aec527ea49d7a58a8356826f9a6e6a999ced649291dfec0bd511ab99fe4724f8b525735c889f80ebc204b6298fe04ddedf0f68b2c03f1c01104ad9728910155661161b31be700d30a89668b316a2e4a47c089ac06689b22e78f66933cff5cc366e676438b1e106c05c30767bae0390f09d052945dd062ae17c09a15ed6a2aa4660047636fe8a8fb1b8a7157b60cea5e0ed257da6b228f03353b90ae0356a0ca5d2fbf4fe96d50387f3f8b93bf2defa0bac8721990815c89bbd3eef83f68dd2994f3e715cb1dacab3108983fdba56ffe4a4a44f8eef405a143262d6d3dc14655687aaf7cdf0eb7ed8640acc28898ce6a9403022039579a4de0822d8a79f695b5ba5eb06fc7c3cda77e4a92a98f6878735f7579b88d351ea9d624bc8f6cb5881ea551a1f6d59f8d7600899fa41580dec55d6e7287d51d669ba6cb2707fd8dde05dc32578acbb6166bf3d1483569559e94babd92ac30d84bbb4d4e13e230f9faea9f03ae67ffcf6bbdbe5b212000e1643e5f86512690b91c09cfca544a4588b864dfcd8ee3080c7d78c9a35c3a739c769cb5cb6c5a6512b276d9963426827705103a83bd0ad101fbec37318e2d0c765c84ad9484f87da1c700ea9e2ab0e3b70c49e8dfd605bc3afc860ddf37ca1193c15ab93a7dd97ca9757d490e6123aa6ab0ee9a5729b3c2732a2d571edee1a46cca13b7a3f1c8bd79ee1b836c4f7eab5e5241f1b3e79810039cd72db6472800db390a00a4c6ed0a680362800dfdea04731be545a38d39ded11efb2407f0ae24d7f9c5f4cdea0afe0ec219b93b55171d8dee04ae576d9ed19aac6b02787abe1808a54ea476f941ee038762972f1ab44db2b51212a1179c1133c5a02653d2c24e74f566bcd12abb051d66ff4beb3296a5813f8288e63db369891396bbf0c58d0233870a7dfc4203143492c2a01a97c0c0518de4d0264e6be39dbdd4fe9de4ef5ab025d8942ef5c4729b1266ffda167a7005c63cde7d6067d7eff6e5bc750524b113d6c75c0cab532a5ab6698085ba4037ed5360cea4c213fcaf69ec3815e57b65c810dfce2a89f44bdb7c3d1cb3a8b3f01372e12a3','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Tablet',NULL,0,NULL,NULL,x'789ced58c16ee33610fd9539da80e3c6cea65beccd75dac4c06ed688b3288aa2075aa22c2212a99294bde9a9bfd1dfeb97f40d25d9b2e3c8498b165da0975d5a1c0e1f67de3c0e33a6ab8f8bc9f57734b9bda2c9d587d9ed6c717f37b99f7dbca50fd20be78557114518588c8c3eb3d2297cd59e0a6b785a625647d2bea3c952c1485aa325894886392f9699f48e4683f3f373ca5764acc8b247325842b150186e944fe14cc65a395e7ad932f31bd5d80da947e3e188facf0073523be5d55afe2bc0766615ae3170cd01446af8b432926aadf48a44c7ce2e35651693c89ca957c08656468bd8786b0ac5c1cea470ec2835366727bd6b7d77d327a1456656140146692d366548b671990ab84a454c4b95f1ee22c364942a1979930370573cf2d2795af2ef07a94938406200194e6b9c6c87c7605a93cc0bff480e8e45940ee9ca90369ea4f0941813d318c84bebe0313116bbe99846e113890408789b13711ad27dfa149edb200d662363daa406e042ae36ec628b21b2a54b392a512a373b6f9cad0b64eb8a8ff3c1c42a515160d03bfa1ec64593c4e071299ccc1440e526968c90525904e6a9bc10cae630a5de3455597c362f57294d33e11c7ddb1f20a57189587980ef648117d673084278bda1f16545c70382bd01e47d7ca9a158ae65668a0a94f1e6b38a14b21197963d7a8b3430c20122ce4ceb80516aaf32a6a1594b8b2defe47635e5e29143ae34ca0b6be0c88315d5f9e280bb9b52352be122560e94c5714b2c54c9ee30cd411cfeb7f2e03cbb0070fddf01630e5c315c841c82586d4998decda78132b665587137e90c816a8941cf6f0c5d56e3661edb244cdc3a41f5e7fedf5134d68d53e7b951abf4cc2af740d3c57ff36422cec10d87cd81e7883e72bdcdf2c2d8706d4c6aeb4ab669a6312c231ebbff15f48b5050aec527ea49d7a58a8356826f9a6e6a999ced649291dfec0bd511ab99fe4724f8b525735c889f80ebc204b6298fe04ddedf0f68b2c03f1c01104ad9728910155661161b31be700d30a89668b316a2e4a47c089ac06689b22e78f66933cff5cc366e676438b1e106c05c30767bae0390f09d052945dd062ae17c09a15ed6a2aa4660047636fe8a8fb1b8a7157b60cea5e0ed257da6b228f03353b90ae0356a0ca5d2fbf4fe96d50387f3f8b93bf2defa0bac8721990815c89bbd3eef83f68dd2994f3e715cb1dacab3108983fdba56ffe4a4a44f8eef405a143262d6d3dc14655687aaf7cdf0eb7ed8640acc28898ce6a9403022039579a4de0822d8a79f695b5ba5eb06fc7c3cda77e4a92a98f6878735f7579b88d351ea9d624bc8f6cb5881ea551a1f6d59f8d7600899fa41580dec55d6e7287d51d669ba6cb2707fd8dde05dc32578acbb6166bf3d1483569559e94babd92ac30d84bbb4d4e13e230f9faea9f03ae67ffcf6bbdbe5b212000e1643e5f86512690b91c09cfca544a4588b864dfcd8ee3080c7d78c9a35c3a739c769cb5cb6c5a6512b276d9963426827705103a83bd0ad101fbec37318e2d0c765c84ad9484f87da1c700ea9e2ab0e3b70c49e8dfd605bc3afc860ddf37ca1193c15ab93a7dd97ca9757d490e6123aa6ab0ee9a5729b3c2732a2d571edee1a46cca13b7a3f1c8bd79ee1b836c4f7eab5e5241f1b3e79810039cd72db6472800db390a00a4c6ed0a680362800dfdea04731be545a38d39ded11efb2407f0ae24d7f9c5f4cdea0afe0ec219b93b55171d8dee04ae576d9ed19aac6b02787abe1808a54ea476f941ee038762972f1ab44db2b51212a1179c1133c5a02653d2c24e74f566bcd12abb051d66ff4beb3296a5813f8288e63db369891396bbf0c58d0233870a7dfc4203143492c2a01a97c0c0518de4d0264e6be39dbdd4fe9de4ef5ab025d8942ef5c4729b1266ffda167a7005c63cde7d6067d7eff6e5bc750524b113d6c75c0cab532a5ab6698085ba4037ed5360cea4c213fcaf69ec3815e57b65c810dfce2a89f44bdb7c3d1cb3a8b3f01372e12a3',x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651f0482d482cc94c56f0cc2d48cc2cca4dcd2b01009ed90ad6',NULL,NULL),(108990,30067,'88d05db3-8bdc-47f1-bb00-6b4a71f98609',5.0,1000.0,24,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Tablet',NULL,0,NULL,NULL,x'789ced58c16edb4610fd95394a80acda72dc14bda9726b0b481cc1725014410f2b72292e4ceeb2bb4b29ce29bfd16b3f2d5fd2374b52a26499b25bb468805e128a3b3bf376e6cddba14774f96e3ebefa91c6379734be7c3bbd99ceef6ec777d37737f4567ae1bcf02aa2080f164f469f58e914de6a4f8535bc2cb1aa2369bfa72f9fffa0f142c1505aa325894886752f1699f48ece06a7a7a7942fc95891650f64b08d62a1f0b8563e8543196be578eb45cbccaf556337a41e8d8667d47f029c93da29af56f25f03b73503b6d170d4a719a0480d8f564652ad945e92e888eb5253663189cc997a076c6869b4888db7a6509cf24c0ac78e52637376d2bbd2b7d77d125a646649114094d6222803b28dcb54c0552a625aa88ca38b0c8b51aa64e44d0eb85dd9c84be769c1bfefa526e10089016438ab71b29d1c83654d322ffc03393816513aa44b43da7892c253624c4c23202fad83c7c45844d3319d8557241220e03047f234a4bbf4313cb74611cc5ac6b44e0dc0854aadd9c50643644b977256a254aeb7de9847e7e0d1251fe7ad8955a2a2c0a18a293f6143d11432785d0827330560b98925a3a45416817f2a2f84b2394ca9374955169fccca654a934c38473ff407286b5c225f1e07e8648217d6731a428abda1d1454548bd4bff5780fd18636a28962b9999a20266bcf9a82285aac4a565afdea21c8c7280cc33e33aa094daab8ce96856d222ecaddceca65c3c70ea9546a3610f1c79b0a33a631cb07753ab66275cc4ca81ba3872898d2ad91ea63988c3ff56ee9d679b0456825b60cc812b868b504b10ac2d0e93dbd92450c7b60c2b0e279d291008bcd1849e5f1bbaa89e1b03c44998c17595ead7fdbf236ed08fa307ba56cbf4c42a774f93f97ff46822cec10e87e800744027b9f3a679616cb846c6b57525e134d5782c237e76ff6be957a1a5dc8d8f7494ae4a1507c574d00abaaec572ba154b467ebd2b5507aca6fa1f11e297f6cc61397e04ae0b13d8a63c92377e7337a0f11cff7006402865cb05525458855504627ce13260502dd9663544cb49791f4481cd12655df0ecd3669dfb996ddcd6c87061c31d80b560ec765c0720e13d2b528abe0d54c2f91242bfac44d58dc008ec6cfc0d1f637e474bf6c09c4bc1db0bfa486551e067a67215c06bf4185aa5f7fecd0dab070ee7f1737be49dfde7d80f4332113a9083bdbcee83f69dd2ad819aeb1e586de549c8c45ebcaedd1f9c94f4def12d48f34246cc7a9a99a2ccea54f5e8bbe1b7d40f6126408da6c868960aa42332d09907589c8509e4d74d7795ae1bf2d31969df93c7fa60d21fee77dd5f1d248ee7a9778c2fa1decfe305fa5769bcb465e15f82e10371b17e1656037c55f819ba5f9475a52e86e77d4215eef6271c7ce970131e9a7098dbaff7e5a0d56756fad26ab6ca7007e1362d75b8d1c8c3a76b7abccef997cfbfbb6d2d2b09e0643152ce5f2651b69009acc9df4a648ad568d8e48fedf6137878cf59b367f8b8e6386d99cbb6dc347ae5a42d732c08ed04ae6a00757bca15f2c3b7780e431cfab01059291bf1e9d09b3dcea1527cd9210267ecc9dc0f365dfc820ad653cf575ac163b93a7ada5db17c7e470d6926a163ba9a919e2bb8c95322235a33d7f6b661c49cba8337c4a17ced188e6a43bcafbeba9ce463c3276f1020a7596cc64c4eb06116124481c90dda14900605e09b3bf420c6e74a0b57ba7340e228734ca820dee497d9f9f815260bae1eaa395e191587f006972a0fcc6ec75035863d395c0e0754a4523f78a3f400c7b10b918b4f1283af4487a844e4052ff0d30220ebc74272fd64b5d72cb00b81b27ea3f79d6351c39ac0477118db66c48ccc49fbdb80053d820377fcdb18246628894527a0940fa101c3a79300997972ceb6f753ba13a9feaec05ca2303dd7594aacc95b7ff2d92a00f758f3ba15a0cfdfc09be131b4d44244f71b1db072a54ce9aa15e6c106e980bf6c1b0675969094dbfd240e53c6a52d9760037f7344cd6cf13afc09ec39b3c59f62821c2b',x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651f0482d482cc94c56f0cc2d48cc2cca4dcd2b01009ed90ad6',NULL,NULL),(108993,30067,'6f5b628b-69da-4a04-a4d5-623b18d1fd5d',5.0,1000.0,24,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Tablet',NULL,0,NULL,NULL,x'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',x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651f0482d482cc94c56f0cc2d48cc2cca4dcd2b01009ed90ad6',NULL,NULL),(109002,5593,'29939129-7d09-4c22-bf3e-491a8a97f4c4',25.0,100.0,8,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'mg','Oral','Tablet',NULL,0,NULL,NULL,NULL,NULL,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(109004,5593,'352dd336-d3f9-4ac5-a000-91d3aef7aca3',25.0,100.0,8,NULL,x'789ca556516edc3610bd0a3f13606ba4455df42b801107ad3f1207b17b805971b4cb9a221592b2a3dea0f7e8c97a92be194a5ac9768ca2fd58602591c3376fdebce1e5f5cdc52fefcdc5c74b7371f9e1eae3d5cdede78bdbabeb8fe6f6c8898dcb2644d3baaf6c8d8d990e6c121f5cc7c1b431997264d351c06bbc2926b6c63ada73e16c3af6de95219b07578e861a4afb98d9601385d144ec4ca63f52eaa8893e1e5c631025943373598f41ac655337e462f64013acbb777620effe00a01814c09e326062fd1e510db72d37c5dd73e09c719635257a4e141a360f47e7190915c35f1b66ebc2614ae1abeb860ea935b14326b666ab20be7ff3c6745876e6ceec99b99821e5631cbc155085ee588024c67f30938d25e747434563e742a99857ca823cb72e4932aef06b09cfd41c71be0b208cfcb3076804204240323e3e28b45de5f59048e8a8683937e4a938f0424081c7e4f62c31b06b57e9291159da01641c2897145d40b18a0b88919de589be9938d373ea5c31f8128a6b5d53a303b7d2e682d2a68727fe323884565d90c513151ce2c7863b14b78901a7f9796b8f405aedabe9392d68ade352750741ed33a77bb63b5df42dac1d8d551d8543064ab61a57d20b008088f80b3548b9f3d8f5257642cf3d68e9b1cbe41ed550c15911bd2805a9cb8955cd80afa04e202b1e1b9b8264677522c53c78ad9490a70b404ce1ae8f89926802ab85510ac81d8fb512407b3924d562622ada4960b6b8a9946112637125d557af32b4a6557dbd4317f077d00a22c75c7a081da0bde93de58ec0ffd06807558a86cc5a568b164561032b4ce945ea79904491628f3c9481a5ff04c224817153f9a5d92ac2d91296eaaa89508bc3762a8598470814188edcc5838f7b617f113a3a200fa92a5d8a99eec96b6353dfa78816c5563f4eadd64150c7ac476c12384491c7a93b25d90620004f1be0259624cf6fc1f4a2972cf1424405bdd43230a5f9713f82ddd950501928f5313d2b4bdb19766a81685464126b062a109c0517c291b5d6dae6d0551bc3e80749648725788175223e2e601df580e455337e365021666d686a2302d03e3558b4db0fe7627307314ec425bf10fdff3ded57b0712f12c8b15bc431b76de01606d3a6d881084c9c8da39d240fde557430fe979d4b14e1164f001287b3ad9467eea94da321a39a7994b6477322d35185900798cf97a176aa0baaa1b9be6dd22fcd585d4390e515d2e9d429f2343a3e901a940ea2a944d7f29fb6cb1e4d59a492844ff19c670a77123ad9dfe143b5797e14103f9b07e6bb5523614ed6a1f9bc63cc4d0051bddc033ba547339d066bedc2095e43a1ba71ed3a5b6bbbc911e8ced753f5e6655db443d25e795484e93c04dbcee85b9de827b2eb78a270808c35dee6ec27db4f6a752a891996aa5dc6ef3eda11dcbac3b12c322bab7c93cb776a850cbe94420c319825041232412b5895c5b7a1ab6df475e4b7e6a737e6eeb0aab0cc17087d9eb18f1a84f6118adba4a663e2d3e7f7ef2e7e932bdd8d79ad73512e7413a33a80743baafbdfd4200a9dc774cd62d3b41b6e774b0ef5fb29b7ea3b582fce99561586b66a9784959b9e6e75e5742f050ef801edbdcbda2d50cf6ab4881ef0636dc47adb5bf9e4372f8042f452a3bffffc6b2a0ace3a7f2ab97f13e3ed29c256769fe6159fb961dc7241c1cddaf5a5125793efaf3fd46b73ae93a37e16513684596f8e631fa72b18adee9695ede7060d6d46cd3ae883f37e8a4a8b7e966ac9eddbc76837a35470cc6d51ef05b1c82502f2124eb6e020ccf50b139b6648e23532fbfbe4e436593daed37c5d589b40bd56cab9958d75e52d9ffd0312baac17','dosage_and_administration','DailyMed SPL Enhanced',0,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(109006,5593,'067c0adc-7322-489d-9baa-1d061b37be36',25.0,100.0,8,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'mg','Oral','Tablet',NULL,0,NULL,NULL,NULL,NULL,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(109008,24143,'29939129-7d09-4c22-bf3e-491a8a97f4c4',25.0,100.0,8,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'mg','Oral','Tablet',NULL,0,NULL,NULL,NULL,NULL,NULL,x'789ca5564b6ee43610ddfb145c8e811e6312c441560318e341e2c58c83b173806ab1d4cd98223524658f7283dc2327cb49f2aa28754bfe214816062c3555f5ead57b55bcbcbeb9f8f9a3b9f87c692e2e3f5d7dbebab9fd72717b75fdf9e4e4e476cf898dcb2644d3ba6f6c8d8d99766c12ef5cc7c1b43199b267d351c06bbc2926b6c63ada72e16c3af6de95219b0757f6861a4adb98d914da7a2ed9e0630aa38988904cbfa7d451137ddcb9c6205a2867e6b2a643cc271f77432e660b74c1ba7b6707f2ee0f008c41016d290336bedb22bae1b6e5a6b87b0e9c33725a53a2e744a161f3b0779e516031fcad61b62eeca692beb96ee8506a133b54666bf50ae6bb77ef4c876367eecc9e998bc7d0f23e0ede0ab842772c8012e37f30968d25e747434573e442a99837ca8e3cb72e4951aef0a9a4616af6c0e1028824ff6a228d0484084cc6c70785baa9bcef12093d153de7863c15079e0868f098dc962506beda54ba4a44d57600393bca254517d0cce20262646779a27326d2f49c3a570c7e09c5b5aea9d1815f69744169d4e489bf0e0ea1553764f1440549fcd87087a63731209b9f3fed11485470353da60358ebb85459426fdbcce99eed460fbd04b5a3b18aa570c800c9e81be24a7501f91111ff421cd2fd3c767d899db0730f567a7c65728fa6a80ead78428483ca2563153bd02ba823c88ac7c6a6a0d659aca8300f5e1b25dce901e927777d4c94441a382d845240e978ac8db06770e3e590549c89a9a8d5406d71532fc3a4cee24aaaafde64884edb7aba812df82dc482d831971eca076c6f7a4fb923346068e4db89a421b3f6d5c2c3e86c60052a26a59e07291545f6a8443978624c813269615c49e0e0c28a749e1d739b8d4e1b6a9174a39a887984528165cf5ddcf9b8953e1c140f4be42155c94b5bd33d79753cf57d8af02e3ef5e3e4bd0ecada674db12a6417452847bb4ad10d40009e3ae135b6a4ce97607a514e967821a2975eba1a98d2fcb81dc1f23c69d02168f6313dcfccbc8d61a7b312ce4545b156a292414e8c29a4aebd57df43696d0ca31fa4a00d8ee005ce891cb9807df4456475a52af2d3acad537f35f574b60858fbf2348619bf3f9799b893298b1ce40fe4ffffc1f70b18ba1759e4d81d04339b3a708be9d3a6d88114acabd5b83bda01bd5021624bbc3ed64425ee303180c421b79596cd7e5b991015d5caa30c055817958e2a8e3c60347d1daa8f5d505dcd3d6f93fed28c75a608b2bc403a659d22d73d83ce7c221d60bab70eedba96275a1d7dbca6514e124e652abdd2c4a311c8fe8e8955cdf5c3db9fcc03f3ddc265d8ae75d53e3f5666874069af1b64a33c69c9d33aae169d303614ead0ae96b4b5c9ab42c1d5f97217dfbc2e9076486aa047dd98f221d87ab3dfea3de0c8795d621476d0b3c65be57ef2f951b64eb531c352d9cb92de463b825bb7db9783decaa2dee4f29dce49065f4a21761d26299412324134389565b84360ebe8cbc8efcd8fefccdd6ed15e594350fcbc891f3985b611d25b9526bb0452fbf5cbc70f17bfc9e5f0064fa7ba42e56a38b1aabb4a43a0c3ff4d1122d579a3d74a560e5ef1bb39d4517f3fd6578710cecb684d8b2e435fd52e61316e8ff7c172bce1020786038ce1b2da060a5aec1ed104fe787265bd29ae06e88bd74721fcd0abbffffc6b6a0ef29d3f95debf89f1fe1861458ff46b3ef3851bc62d1944dc2c9782f4e3aaae059c5efe542fe0b9ae96ba3744a00de17260f6631fa74b1b3d732badec3fb79168b59396c11f9cf753743ae8e9d03db9c7fb18ed6af70a9ed92af522118bdc3a2037e1670d12425dbe30b1698624f3472e0b7d72720fad43afd3ba5d580e867a2195bc9595a5122c9ffd03b340c670',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(109010,24143,'352dd336-d3f9-4ac5-a000-91d3aef7aca3',25.0,100.0,8,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
